Scolaris Content Display Scolaris Content Display

Entrenamiento de las aptitudes sociales para el Trastorno de Hiperactividad y Déficit de Atención (THDA) en niños de cinco a 18 años de edad

Esta versión no es la más reciente

Contraer todo Desplegar todo

Referencias

Referencias de los estudios incluidos en esta revisión

Abikoff 2004 {published data only}

Abikoff H, Hectman L, Klein RG, Gallagher R, Fleiss K, Etcovitch J, et al. Social functioning in children with ADHD treated with long‐term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry 2004;43(7):820‐29.
Abikoff H, Hectman L, Klein RG, Weiss G, Fleiss K, Etcovitch J, et al. Symptomatic improvement in children with ADHD treated with long‐term methylphenidate and multimodal psychosocial treatment. Journal of American Academy of Child and Adolescent Psychiatry 2004;43(7):802‐11.
Hechtman L, Abikoff H, Klein RG, Weiss G, Respitz C, Kouri J, et al. Academic achievement and emotional status of children with ADHD treated with long‐term methylphenidate and multimodal psychosocial treatment. Journal of American Academy of Child and Adolescent Psychiatry 2004;43(7):812‐19.
Klein RG, Abikoff H, Hechtman L, Weiss G. Design and rationale of controlled study of long‐term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of American Academy of Child and Adolescent Psychiatry 2004;43(7):792‐801.

Antshel 2003 {published data only}

Antshel KM, Remer R. Social skills training in children with attention deficit hyperactivity disorder: a randomized‐controlled clinical trial. Journal of Clinical Child and Adolescent Psychology 2003;32(1):153‐65.

Bloomquist 1991 {published data only}

Bloomquist ML, August GJ, Ostrander R. Effects of a school‐based cognitive‐behavioral intervention for ADHD children. Journal of Abnormal Child Psychology 1991;19(5):591‐605.

Cohen 1981 {published data only}

Cohen NJ, Sullivan J, Minde K, Novak K, Helwig C. Evaluation of the relative effectiveness of methylphenidate and cognitive behavior modification in the treatment of kindergarten‐aged hyperactive children. Journal of Abnormal Child Psychology 1981;9(1):43‐54.

MTA 1999 {published data only}

Arnold LE, Abikoff HB, Cantwell DP, Conners CK, Elliott GR, Greenhill LL, et al. NIMH collaborative multimodal treatment study of children with ADHD (MTA): design methodology and protocol evolution. Journal of Attention Disorder 1997;2(3):141‐58.
Arnold LE, Chuang S, Davies M, Abikoff HB, Conners CK, Elliot GR, et al. Nine months of multicomponent behavioral treatment for ADHD and effectiveness of MTA fading procedures. Journal of Abnormal Child Psychology 2004;32(1):39‐51.
Arnold LE, Sachs L, Kraemer HC, Abikoff HB, Conners CK, Greenhill LL, et al. Effects of ethnicity on treatment attendance, stimulant response/dose, and 14‐month outcome in ADHD. Journal of Consulting and Clinical Psychology 2003;71(4):713‐27.
Hinshaw SP, March JS, Abikoff H, Arnold LE, Cantwell DP, Conners CK, et al. Comprehensive assessment of childhood attention‐deficit hyperactivity disorder in the context of a multisite, multimodal clinical trial. Journal of Attention Disorder 1997;1(4):217‐34.
Jensen PS, Arnold LE, Swanson JM, Vitiello B, Abikoff HB, Greenhill LL, et al. 3‐Year follow‐up of the NIMH MTA study. Journal of American Academy of Child and Adolescent Psychiatry 2007;46(8):989‐1002.
Jensen PS, Hinshaw SP, Kraemer HC, Lenora N, Newcorn JH, Abikoff HB, et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. Journal of American Academy of Child and Adolescent Psychiatry 2001;40(2):147‐58.
MTA Cooperative Group. A 14‐month randomized clinical trial of treatment strategies for attention‐deficit/hyperactivity disorder. Archives of General Psychiatry 1999;56(12):1073‐86.
MTA Cooperative Group. Moderators and mediators of treatment response for children with attention‐deficit/hyperactivity disorder. Archives of General Psychiatry 1999;56(12):1088‐96.
MTA Cooperative Group. National Institute of Mental Health multimodal treatment study of ADHD follow‐up: 24‐month outcomes of treatment strategies for attention‐deficit/hyperactivity disorder. Pediatrics 2004;113(4):754‐61.
MTA Cooperative Group. National Institute of Mental Health multimodal treatment study of ADHD follow‐up: changes in effectiveness and growth after the end of treatment. Pediatrics 2004;113(4):762‐9.
Molina BSG, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS, et al. The MTA at 8 years: prospective follow‐up of children treated for combined‐type ADHD in a multisite study. Journal of American Academy of Child and Adolescent Psychiatry 2009;48(5):484‐500.
Swanson J. The MTA follow‐up into adolescence: implications for personalized treatment.. Oral presentation at The International Society for Research in Child and Adolescent Psychopathology Conference; 2009 June 19; Seattle. Seattle: ISRCAP, 2009.
Wells KC, Pelham WE, Kotkin RA, Hoza B, Abikoff HB, Abramowitz A, et al. Psychosocial treatment strategies in the MTA study: rationale, methods, and critical issues in design and implementation. Journal of Abnormal Child Psychology 2000;28(6):483‐505.

Pfiffner 1997 {published data only}

Pfiffner L, McBurnett K. Social skills training with parent generalization: treatment effects for children with attention deficit disorder. Journal of Consulting and Clinical Psychology 1997;65(5):749‐57.

Pfiffner 2007 {published data only}

Pfiffner LJ, Mikami AY, Huang‐Pollock C, Easterlin B, Zalecki C, McBurnett K. A randomized, controlled trial of integrated home‐school behavioral treatment for ADHD, predominantly inattentive type. Journal of American Academy of Child and Adolescent Psychiatry 2007;46(8):1041‐50.

Tutty 2003 {published data only}

Tutty S, Gephart H, Wurzbacher K. Enhancing behavioral and social skill functioning in children newly diagnosed with attention‐deficit hyperactivity disorder in a pediatric setting. Developmental and Behavioral Pediatrics 2003;24(1):51‐7.

van der Oord 2007 {published data only}

van der Oord S, Prins PJM, Oosterlaan J, Emmelkamp PMG. Does brief, clinically based, intensive multimodal behaviour therapy enhance the effects of methylphenidate in children with ADHD?. European Child and Adolescent Psychiatry 2007;16(1):48‐57.

Waxmonsky 2010 {published data only}

Waxmonsky JG, Waschbusch DA, Pelham WE, Draganac‐Cardona L, Rotella B, Ryan L. Effects of atomoxetine with and without behavior therapy on the school and home functioning of children with attention‐deficit/hyperactivity disorder. Journal of Clinical Psychiatry 2010;71(11):1535‐51.

Yuk‐chi 2005 {published data only}

Yuk‐chi S. Effectiveness of Methylphenidate and Combined Treatment (Methylphenidate and Psychosocial Treatment) for Chinese Children with Attention‐Deficit/Hyperactivity Disorder in a Community Mental Health Center (PhD theses). Hong Kong: The Chinese University of Hong Kong, 2005.

Referencias de los estudios excluidos de esta revisión

Abikoff 1985 {published data only}

Abikoff H, Gittelman R. Hyperactive children treated with stimulants. Is cognitive training a useful adjunct?. Archives of General Psychiatry 1985;42(10):953‐61.

Carlson 2000 {published data only}

Carlson CL, Tamm L. Responsiveness of children with attention‐deficit/hyperactivity disorder to reward and response cost: differential impact on performance and motivation. Journal of Consulting and Clinical Psychology 2000;68(1):73‐83.

Carlson 1992 {published data only}

Carlson CL, Pelham WE, Milich R, Dixon J. Single and combined effects of methylphenidate and behavior therapy on the classroom performance of children with attention‐deficit hyperactivity disorder. Journal of Abnormal Child Psychology;1992 April;20(2):213‐32.

Chang 2004 {published data only}

Chang CC, Tsou KS, Shen WW, Wong CC, Chao CC. A social skills training program for preschool children with attention‐deficit/hyperactivity disorder. Chang Gung Medical Journal 2004;27(12):918‐23.

Corkum 2005 {published data only}

Corkum PV, McKinnon MM, Mullane JC. The effect of involving classroom teachers in a parent training program for families of children with ADHD. Child & Family Behavior Therapy 2005;27(4):29‐49.

Döpfner 2004 {published data only}

Döpfner M, Breuer D, Schürmann S, Metternich TW, Rademacher C, Lehmkuhl G. Effectiveness of an adaptive multimodal treatment in children with attention‐deficit/hyperactivity disorder ‐ global outcome. European Child and Adolescent Psychiatry 2004;13(suppl 1):117‐29.

Ercan 2005 {published data only}

Ercan ES, Varan A, Deniz Ü. Effects of combined treatment on turkish children diagnosed with attention‐deficit/hyperactivity disorder: a preliminary report. Journal of Child and Adolescent Psychopharmacology 2005;15(2):203‐19.

Evans 2000 {published data only}

Evans SW, Axelrod JL, Sapia JL. Effective school‐based mental health interventions: advancing the social skills training paradigm. Journal of School Health 2000;70(5):191‐4.

Fabiano 2003 {published data only}

Fabiano GA, Pelham WE. Improving the effectiveness of behavioral classroom interventions for attention‐deficit/yyperactivity disorder: a case study. Journal of Emotional and Behavioral Disorders 2003;11(2):122‐8. [DOI: 10.1177/106342660301100206]

Feinfield 2004 {published data only}

Feinfield KA, Baker BL. Empirical support for a treatment program for families of young children with externalizing problems. Journal of Clinical Child and Adolescent Psychology 2004;33(1):182‐95.

Fenstermacher 2006 {published data only}

Fenstermacher K, Olympia D, Sheridan SM. Effectiveness of a computer‐facilitated, interactive social skills training program for boys with attention deficit hyperactivity disorder. School Psychology Quarterly 2006;21(2):197‐224.

Frankel 1997 {published data only}

Frankel F, Myatt R, Cantwell DP, Feinberg DT. Use of the child behavior checklist and DSM‐III‐R diagnosis in predicting outcome of children´s social skills training. Journal of Behavior Therapy and Experimental Psychiatry 1997;28(2):149‐61.

Frölich 2002 {published data only}

Frölich J, Döpfner M, Berner W, Lehmkuhl G. Combined cognitive behavioural treatment with parent management training in ADHD [Behandlungseffekte kombinierter kognitiver Verhaltenstherapie mit Elterntraining bei hyperkinetischen Kindern]. Praxis der Kinderpsychologie und Kinderpsychiatrie 2002;51:476‐93.

Gadow 1985 {published data only}

Gadow KD. Relative efficacy of pharmacological, behavioral, and combination treatments for enhancing academic performance. Clinical Psychology Review 1985;5(5):513‐33.

Gol 2005 {published data only}

Gol D, Jarsus T. Effect of a social skills training group on everyday activities of children with attention deficit‐hyperactivity disorder. Developmental Medicine and Child Neurology 2005;47(8):539‐45.

Gonzalez 2002 {published data only}

Gonzalez LO, Sellers EW. The effects of a stress‐management program on self‐concept, locus of control, and the acquisition of coping skills in school‐age children diagnosed with attention deficit hyperactivity disorder. Journal of Child and Adolescent Psychiatric Nursing 2002;15(1):5‐15.

Hinshaw 1984 {published data only}

Hinshaw SP, Whalen CK, Henker B. Cognitive‐behavioral and pharmacological interventions for hyperactive boys: comparative and combined effects. Journal of Consulting and Clinical Psychology 1984;52(5):739‐49.

Hinshaw 2000 {published data only}

Hinshaw SP, Owens EB, Wells KC, Kraemer HC, Abikoff HB, Arnold LE, et al. Family processes and treatment outcome in the MTA: negative/ineffective parenting practices in relation to multimodal treatment. Journal of Abnormal Child Psychology 2000;28(6):555‐68.

Horn 1990 {published data only}

Horn WF, Ialongo N, Greenberg G, Packard T, Smith‐Winberry C. Additive effects of behavioral parent training and self‐control therapy with attention deficit/ hyperactivity disordered children. Journal of Clinical Child Psychology 1990;19(2):98‐110.

Jensen 1999 {published data only}

Jensen PS. Fact versus fancy concerning the multimodal treatment study for attention‐deficit/hyperactivity disorder. Canadian Journal of Psychiatry 1999;44(10):975‐80.

Jensen 2001 {published data only}

Jensen PS, Hinshaw SP, Swanson JM, Greenhill LL, Conners CK, Arnold LE. Findings from the NIMH multimodal treatment study of ADHD (MTA): implications and applications for primary care providers. Journal of Developmental and Behavioral Pediatrics 2001;22(1):60‐73.

Klein 1997 {published data only}

Klein RG, Abikoff H. Behavior therapy and methylphenidate in the treatment of children with ADHD. Journal of Attention Disorders 1997;2(2):89‐114.

Kolko 1990 {published data only}

Kolko DJ, Loar LL, Sturnick D. Inpatient social‐cognitive skills training groups with conduct disordered and attention deficit disordered children. Journal of Child Psychology and Psychiatry 1990;31(5):737‐48.

Kolko 1999 {published data only}

Kolko DJ, Bukstein OG, Barron J. Methylphenidate and behavior modification in children with ADHD and comorbid ODD or CD: main and incremental effects across settings. Journal of American Academic Child and Adolescent Psychiatry 1999;38(5):578‐86.

Langberg 2008 {published data only}

Langberg JM, Epstein JN. Efficacy of an organization skills intervention to Improve the academic functioning of students with attention‐deficit/hyperactivity disorder. School Psychology Quarterly 2008;23(3):407‐17.

Langberg 2010 {published data only}

Langberg JM, Arnold LE, Flowers AM, Epstein JN, Altaye M, Hinshaw SP, et al. Parent‐reported homework problems in the MTA study: evidence for sustained improvement with behavioral treatment. Journal of Clinical Child and Adolescent Psychology 2010;39(2):220‐33.

Lösel 2006 {published data only}

Lösel F, Beelmann A, Stemmler M, Jarusch S. Prevention of social behaviour problems at preeschool age. Evaluation of the parent and child training program package [Prävention von Problemen des Sozialverhaltens im Vorschulalter. Evaluation des Eltern‐ und Kindertrainings EFFEKT]. Zeitschrift für Klinische Psychologie und Psychotherapie 2006;35(2):127‐39.

Miranda 2002 {published data only}

Miranda A, Presentación J, Soriano M. Effectiveness of a school‐based multicomponent program for the treatment of children with ADHD. Journal of Learning Disabilities 2002;35(6):547‐63.

Miranda 2006a {published data only}

Miranda A, Jarque S, Rosel J. Treatment of children with ADHD: psychopedagogical program at school versus psychostimulant medication. Psicothema 2006;18(3):335‐41.

Miranda 2006b {published data only}

Miranda A, Jarque S, Tarraga R. Interventions in school settings for students with ADHD. Exceptionality 2006;14(1):35‐52.

Molina 2008 {published data only}

Molina BSG, Flory K, Bukstein OG, Greiner AR, Baker JL, Krug V, Evans SW. Feasibility and preliminary efficacy of an after‐school program for middle schoolers with ADHD. Journal of Attention Disorders 2008;12(3):207‐17.

MTA 2009 {published data only}

Breggin PR, Klein RG, Jensen PS. [Letters to editors]. Archives of General PsychiatrySeptember 2009.

Pelham 1980 {published data only}

Pelham WE, Schnedler RW, Bologna NC, Contreras JA. Behavioral and stimulant treatment of hyperactive children: a therapy study with methylphenidate probes in a within‐subject design. Journal of Applied Behavior Analysis 1980;13(2):221‐36.

Pelham 1993 {published data only}

Pelham WE, Carlson C, Sams SE, Vallano G, Dixon JM, Hoza B. Separate and combined effects of methyphenidate and behavior modification on boys with attention deficit/hyperactivity disorder in the classroom. Journal of Consulting and Clinical Psychology 1993;61(3):506‐15.

Pelham 2000 {published data only}

Pelham WE, Gnagy EM, Greiner AR, Hoza B, Hinshaw SP, Swanson JM. Behavioral versus behavioral and pharmacological treatment of the ADHD children attending a summer treatment program. Journal of Abnormal Child Psychology 2000;28(6):507‐25.

Pelham 2005 {published data only}

Pelham WE, Burrows‐MacLean L, Gnagy EM, Fabiano GA, Coles EK, Tresco KE, et al. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD. Experimental and Clinical Psychopharmacology 2005;13(2):111‐26.

Rosén 1984 {published data only}

Rosén LA, O´Leary SG, Joyce AS Conway G, Pfiffner L. The importance of prudent negative consequences for maintaining the appropriate behavior of hyperactive students. Journal of Abnormal Child Psychology 1984;12(4):581‐604.

Waxmonsky 2008 {published data only}

Waxmonsky J, Pelham WE, Gnagy E, Cummings MR, O´Connor B, Majumdar A, et al. The efficacy and tolerability of methylphenidate and behavior modification in children with attention‐deficit/hyperactivity disorder and severe mood dysregulation. Journal of Child and Adolescent Psychopharmacology 2008;18(6):573‐88.

Webster‐Stratton 2001 {published data only}

Webster‐Stratton C, Reid J, Hammond M. Social skills and problem‐solving training for children with early‐onset conduct problems: who benefits?. Journal of Child Psychology and Psychiatry 2001;42(7):943‐52.

Webster‐Stratton 2004 {published data only}

Webster‐Stratton C. Reid J. Strengthening social and emotional competence in young children ‐ the foundation for early school readiness and success. Incredible Years classroom social skills and problem‐solving curriculum. Infants and Young Children 2004;17(2):96‐113.

Williams 1993 {published data only}

Williams RA, Horn S, Daley SP, Nader PR. Evaluation of access to care and medical and behavioral outcomes in a school‐based intervention program for attention‐deficit hyperactivity disorder. Journal of School Health 1993;63(7):294‐7.

Wolraich 1978 {published data only}

Wolraich M, Drummond T, Salomon MK, O´Brian ML, Sivage C. Effects of methylphenidate alone and in combination with behavior modification procedures on the behavior and academic performance of hyperactive children. Journal of Abnormal Child Psychology 1978;6(1):149‐61.

Referencias de los estudios en curso

Safren 2011 {published data only}

Compensatory executive functioning skills training for adolescents with ADHD.. Ongoing study October 2009. Estimated study completion date: May 2012..

Storebø 2011 {published data only}

Randomised social‐skills training and parental training plus standard treatment versus standard treatment of children with attention deficit hyperactivity disorder ‐ The SOSTRA trial.. Ongoing study August 2009. Finished August 2011..

Achenbach 1991

Achenbach TM. Integrative Guide to the 1991 CBCL/4‐18,YSR, and the TRF Profiles. Burlington, VT: University of Vermont, Department of Psychology, 1991.

APA 1980

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM‐III). 3rd Edition. Washington, DC: American Psychiatric Association, 1980.

APA 1987

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM‐III‐R). 3rd Edition. Washington, DC: American Psychiatric Association, 1987.

APA 1994

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM‐IV). 4th Edition. Washington, DC: American Psychiatric Association, 1994.

APA 2000

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM‐IV‐TR. 4th Edition. Washington, DC: American Psychiatric Association, 2000.

Attkinson 1982

Attkinsson CC, Zwick R. The client satisfaction questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome. Evaluation and Program Planning 1982;5(3):233‐7.

Barkley 1997

Barkley RA. A review stimulant drug research with hyperactive children. Journal of Child Psychology and Psychiatry 1977;18(2):137‐65.

Barkley 1998

Barkely RA. Attention‐Deficit/Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 2nd Edition. New York: Guildford, 1998.

Barkley 2002

Barkely RA, Fischer M, Smallish L, Fletcher K. The persistence of attention‐deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. Journal of Abnormal Psychology 2002;111(2):279‐89.

Berkley 1996

Berkey CS, Mosteller F, Lau J, Antman EM. Uncertainty of the time of first significance in random effects cumulative meta‐analysis. Controlled Clinical Trials October 1996;17(5):357‐71.

Biederman 1998

Biederman J, Faraone SV, Taylor A, Sienna M, Williamson S, Fine C. Diagnostic continuity between child and adolescent ADHD: Findings from a longitudinal clinical sample. Journal of American Academic Child and Adolescence Psychiatry 1998;37(3):305‐13.

Biederman 2000

Biederman J, Mick E, Faraone SV. Age‐dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. American Journal of Psychiatry 2000;157(5):816‐8.

Block 1998

Block S. Attention‐deficit disorder. In: Findling R, Blumer J editor(s). Child and Adolescent Psychopharmacology. Vol. 45, London: WB Saunders Company, 1998:1053‐84.

Boo 2007

Boo de GM, Prins PJM. Social incompetence in children with ADHD: possible moderators and mediators in social‐skills training. Clinical Psychology Review 2007;27(1):78‐97.

Brok 2008

Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta‐analyses. Journal of Clinical Epidemiology 2008;61(8):763‐9.

Brok 2009

Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta‐analyses may be inconclusive ‐ Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta‐analyses. International Journal of Epidemiology Feb 2009;38(1):287‐98.

BUP 2008

BUP ‐ Børne‐ og Ungdomspsykiatrisk Selskab. Reference programme for assessment and treatment of children and young people with ADHD [Referenceprogram for udredning og behandling af børn og unge med ADHD [Danish]]. http://www.bupnet.dk/media/ADHDReferenceprogram080508_jsb[1].pdf(accessed March 2010).

Bussing 2008

Bussing R, Fernadez M, Harwood M, Hou W, Garvan CW, Eyberg SM, Swanson JM. Parent and teacher SNAP‐IV ratings of attention deficit/hyperactivity disorder symptoms ‐ psychometric properties and normative ratings from a school district sample. Assessment September 2008;15(3):317‐28.

Castellanos 2006

Castellanos FX, Sonuga‐Barke EJ, Milham MP, Tannock R. Characterizing cognition in ADHD: beyond executive dysfunction. Trends in Cognitive Sciences 2006;10(3):117‐23.

Cherland 1999

Cherland E, Fritzpark R. Psychotic side effects of psychostimulants: a 5‐year review. Canadian Journal of Psychiatry 1999;44(8):811‐3.

Conners 1998

Conners KC, Sitarenios G, Parker JDA, Epstein JN. The revised Conners´ Parent Rating Scale (CPRS‐R): factor structure, reliability, and criterion validity. Journal of Abnormal Child Psychology 1998;26(4):257‐68.

Conners 2008a

Conners KC. Conners Comprehensive Behavior Rating Scales (Conners CBRS). Toronto, Canada: Multi‐Health Systems Inc, 2008.

Conners 2008b

Conners KC. Conners 3. Toronto, Canada: Multi‐Health Systems Inc, 2008.

Cyr 1998

Cyr M, Brown C. Current drug therapy recommendations for the treatment of attention‐deficit/hyperactivity disorder. Drugs 1998;56(2):215‐23.

Dalsgaard 2002

Dalsgaard S, Mortensen PB, Frydenberg M, Thomsen PH. Conduct problems, gender and adult psychiatric outcome of children with attention‐deficit hyperactivity disorder. British Journal of Psychiatry.  2002;181(5):416‐21.

Donner 2002

Donner A, Klar N. Issues in the meta‐analysis of cluster randomised trials. Statistics in Medicine 2002;21(19):2971–80.

Fohlmann 2009a

Fohlmann AH. Social skills training [Social færdighedstræning [Danish]]. Merete Nordentoft, Marianne Melau, Tina Iversen & Sanne Kjær (editor(s): Psychosis in the young. Symptoms, treatment and the future [Psykose hos unge. Symptomer, behandling og fremtid [Danish]]. Copenhagen: Psykiatrifondens Forlag, 2009:161‐89.

Fohlmann 2009b (pers comm)

Fohlmann AH. Personal communication ‐ email correspondenceApril 2009.

Ford 2003

Ford T, Goodman R, Meltzer H. The British Child and Adolescent Mental Health Survey 1999: the prevalence of DSM‐IV disorders. Journal of the American Academy of Child and Adolescent Psychiatry 2003;42(10):1203–11.

Gadow 1990

Gadow KD, Nolan EE, Sverd J, Sprafkin J, Paolicelli L. Methylphenidate in aggressive‐hyperactive boys: In effects on peer aggression in public school settings. Journal of American Academy of Child and Adolesent Psychiatry 1990;29(5):710‐8.

Gillberg 1997

Gillberg C, Melander H, von Knorring A, Janols L, Thernlund G, Hagglof B, et al. Long‐term stimulant treatment of children with attention‐deficit hyperactivity disorder symptoms. A randomised, double‐blind, placebo‐controlled trial. Archives of General Psychiatry 1997;54(9):857‐64.

Gilmore 2001

Gilmore A, Milne R. Methylphenidate in children with hyperactivity: review and cost‐utility analysis. Pharmacoepidemology and Drug Safety 2001;10(2):85‐94.

Gluud 2009

Gluud C, Nikolova D, Klingenberg SL, Alexakis N, Als‐Nielsen B, D'Amico G, et al. Cochrane Hepato‐Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs). Available online at: http://mrw.interscience.wiley.com/cochrane/clabout/articles/LIVER/frame.html2009.

Goldman 1998

Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Diagnosis and treatment of attention‐deficit disorder in children and adolescents. JAMA 1998;279(14):1100‐7.

Gresham 1990

Gresham FM, Elliot SN. Social Skills Rating System. Circle Pines, MN: Assistance Service, 1990.

Hectman 1983

Hechtman L, Weiss G. Long‐term outcome of hyperactive children. American Journal of Orthopsychiatry 1983;53(3):532‐41.

Higgins 2011

Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Available from www.cochrane‐handbook.org, The Cochrane Collaboration, 2011.

ICH 1996

International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline. Guideline for good Clinical Practice E6(R1). 1996. http://www.ich.org/products/guidelines/efficacy/efficacy‐single/article/good‐clinical‐practice.html (accessed 6 May 2011).

Kadesjö 2001

Kadesjö B, Gillberg C. The comorbidity of ADHD in the general population of Swedish school‐age children. Journal of Child Psychology and Psychiatry 2001;42(4):487‐92.

Kadesjö 2002

Kadesjö B. ADHD in Children and Adults. ADHD hos barn och vuxna [Swedish]. Stockholm: Socialstyrelsen, 2002.

Kavale 1997

Kavale KA, Mathur SR, Forness SR, Rutherford Jr RB, Quinn MM. Effectiveness of social skills training for students with behaviour disorders: A meta‐analysis. Advances in Learning and Behavioral Disabilities 1997;11:1‐26.

Keus 2010

Keus F, Wetterslev J, Gluud C, van Laarhoven CJ. Evidence at a glance: error matrix approach for overviewing available evidence. BMC Medical Research Methodology 2010;10(90):http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2959031/ (accessed 10 October 2011).

Kjaergard 2002

Kjaergard LL, Gluud C. Citation bias of hepato‐biliary randomised clinical trials. Journal of Clinical Epidemiology 2002;55(4):407‐10.

Klassen 1999

Klassen A, Miller A, Raina P, Lee S K, Olsen L. Attention‐deficit hyperactivity disorder on children and youth: a quantitative systematic review of the efficacy of different management strategies. Canadian Journal of Psychiatry 1999;44(10):1007‐16.

Lakes 2011

Lakes KD, Swanson JM, Riggs M. The reliability and validity of the English and Spanish Strengths and Weaknesses of ADHD and Normal Behavior rating scales in a preschool sample: continuum measures of hyperactivity and inattention. Journal of Attention Disorders August 2011;1:1‐7.

Landau 1991

Landau S, Moore LA. Social skill deficit in children with attention‐deficit hyperactivity disorder. School Psychology Review 1991;20(2):235‐51.

Lau 1995

Lau, J, Schmid, C. H, & Chalmers, T. C. Cumulative meta‐analysis of clinical trials builds evidence for exemplary medical care. Journal Of Clinical Epidemiology 1995;48:45‐57. [doi: 10.1016/0895‐4356(94)00106‐Z]

Liberman 1988

Liberman RP. Social skills training. In: Liberman RP editor(s). Psychiatric Rehabilitation of Chronic Mental Patients. Washington, DC: American Psychiatric Press, 1988.

Mager 2005

Mager W, Milich R, Harris MJ, Howard A. Intervention group for adolescents with conduct problems: Is aggression harmful or helpful?. Journal of Abnormal Child Psychology 2005;33(3):349‐62.

Majewicz‐Hefley 2007

Majewicz‐Hefley A, Carlson JS. A meta‐analysis of combined treatments for children diagnosed with ADHD. Journal of Attention Disorders 2007;10(3):239‐50.

Malone 1993

Malone MA, Swanson JM. Effects of methylphenidate on impulsive responding in children with attention deficit hyperactivity disorder. Journal of Child Neurology 1993;8(2):157‐63.

Mannuzza 1990

Mannuzza S, Klein RG, Konig PH, Giampino TL . Childhood predictors of psychiatric status in the young adulthood of hyperactive boys: a study controlling for chance associations. In: Robins LN, Rutter M editor(s). Straight and Devious Pathways from Childhood to Adulthood. New York: Cambridge University Press, 1990:279‐99.

Mannuzza 1998

Mannuzza S, Klein RG, Bessler A,  Malloy P, LaPadula M. Adult psychiatric status of hyperactive boys grown up. American Journal of Psychiatry 1998;155(4):493‐8.

NICE 2009

National Collaborating Centre for Mental Health commissioned by the National Institute for Health and Clinical Excellence. Attention Deficit Hyperactivity Disorder: Diagnosis and Management of ADHD in Children, Young People and Adults. National Clinical Practice Guideline Number 72. Leicester and London: The British Psychological Society and The Royal College of Psychiatrists, 2009.

Nigg 2005

Nigg JT, Casey BJ. An integrative theory of attention‐deficit/hyperactivity disorder based on the cognitive and affective neurosciences. Development and Psychopathology 2005;17(3):785‐806.

Pasini 2007

Pasini A, Paloscia C, Alessandrelli R, Porfirio MC, Curatolo P. Attention and executive functions profile in drug naive ADHD subtypes. Brain and Development 2007;29(7):400‐8.

Pineda 2003

Pineda DA, Lopera F, Palacio JD, Ramirez D, Henao GC. Prevalence estimations of attention‐deficit/hyperactivity disorder: differential diagnoses and comorbidities in a Columbian sample. International Journal of Neuroscience 2003;113(1):49‐71.

Pliszka 1998

Pliszka S. The use of psychostimulants in the paediatric patient. In: Findling R, Blumer J editor(s). Child and Adolescent Psychopharmacology (The Pediatric Clinics of North America). Vol. 45, London: WB Saunders Company, 1998:1085‐98.

Pliszka 1999

Pliszka SR, Carlson CL, Swansom JM. ADHD with comorbid disorder. Clinical assessment and management. New York: Guildford Press, 1999.

Polanczyk 2007

Polanczyk G, Rohde LA. Epidemiology of attention‐deficit/hyperactivity disorder across the lifespan. Current Opinion in Psychiatry 2007;20(4):386‐92.

Pringsheim 2011

Pringsheim T Steeves T. Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders. Cochrane Database of Systematic Reviews 2011, Issue 4. [DOI: 10.1002/14651858.CD007990.pub2]

RevMan 2011 [Computer program]

The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.

Schachar 1997

Schachar RJ, Tannock R, Cunningham C, Corkum PV. Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate. Journal of the American Academy of Child and Adolescent Psychiatry 1997;36(6):754‐63.

Schmidt 2009

Schmidt S, Peterman F. Developmental psychopathology: attention deficit hyperactivity disorder(ADHD). BMC Psychiatry 2009;9(58):(http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751746/ ‐ accessed online 25 September 2011). [DOI: 10.1186/1471‐244X‐9‐58]

Schultz 1995

Schultz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408‐12.

Sergeant 2003

Sergeant JA, Geurts H, Huijbregts S, Scheres A, Oosterlaan J. The top and the bottom of ADHD: a neuropsychological perspective. Neuroscience and Biobehavioural Reviews 2003;27(7):583‐92.

Spencer 1996

Spencer T, Biederman J,  Wilens T, Harding M, O´Donnel D,  Griffin S. Pharmacotherapy of attention‐deficit hyperactivity disorder across the life cycle. Journal of the American Academy of Child and Adolescent Psychiatry 1996;35(4):409‐32.

Swanson 1995

Swanson JM, Lerner M, Williams L. More frequent diagnosis of attention deficit‐hyperactivity disorder. New England Journal of Medicine 1995;333(14):944.

Swanson 2007

Swanson JM, Hinshaw SP, Arnold LE, Gibbons RD, Marcus S, Hur K, et al. Secondary evaluations of MTA 36‐month outcomes: propensity score and growth mixture model analysis. Journal of American Academy of Child and Adolescent Psychiatry 2007;46(8):1003‐14.

Thalheimer 2002

Thalheimer W, Cook S. How to calculate effect sizes from published research articles: a simplified methodology. from http://work‐learning.com/effect_sizes.htm. (acessed 28 May 2011).

Thomson 2011

Thomson A, Maltezos S, Paliokosta E, Xenitidis K. Amfetamine for attention deficit hyperactivity disorder inpeople with intellectual disabilities. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD007009.pub2]

Thorlund 2009

Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JP, Thabane L, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta‐analyses?. International Journal of Epidemiology 2009;38(1):276‐86.

US FDA 2011

US Food, Drug Administration. Communication about an ongoing safety review of stimulant medications used in children with attention‐deficit/hyperactivity disorder (ADHD). http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm165858.htm (accessed 6 May 2011).

Van der Oord 2008

Van der Oord S, Prins PJM, Oosterlaan J, Emmelkamp PMG. Efficacy of methylphenidate, psychosocial treatments and their combination in school‐aged children with ADHD: a meta‐analysis. Clinical Psychology Review 2008;28(5):783‐800.

Walcott 2004

Walcott CM, Landau S. The relation between disinhibition and emotion regulation in boys with attention deficit hyperactivity disorder. Journal of Clinical Child and Adolescent Psychology 2004;33(4):772‐82.

Wetterslev 2008

Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology 2008;61(1):64‐75.

Whalen 1985

Whalen CK, Henker B. The social world of the hyperactive (ADHD) children. Clinical Psychology Review 1985;5:447‐78.

WHO 1992

World Health Organisation. The ICD‐10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organisation, 1992.

Wolraich 2007

Wolraich ML, McGuinn L, Doffing M. Treatment of attention deficit hyperactivity disorder in children and adolescents: safety considerations. Drug Safety 2007;30(1):17‐26.

Wood 2008

Wood L, Egger M, Gluud LL, Schultz K, Jüni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ 2008;336(7644):601‐5.

Zametkin 1987

Zametkin AJ, Rapoport JL. Neurobiology of attention deficit disorder with hyperactivity: where have we come in 50 years?. Journal of American Academy of Child and Adolescent Psychiatry 1987;26(5):676‐86.

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Abikoff 2004

Methods

Randomised Clinical Trial

Participants

103 children( age 7.0 ‐ 9.9 years) participated in the study.

Sex: 93% boys, 7% girls

Ethnicity: 84% white, 13% African American, 2% Hispanic, and 1% other.

Sample size calculation is not reported.

Comorbidity: 53.4% had oppositional defiant disorder, 30% had conduct disorder, 16.5% anxiety disorder.

All the participants in the study received psychostimulant medication.

84 of the children (81.2%) lived with both parents, 13 (12.6%) with one parent and 6 (5.8%) with their mother and stepfather.

Setting: Outpatient clinic in two large medicals Centre in New York and Montreal.

Baseline between group differences: No differences except on socioeconomic status, where there were differences between the M alone and M + ACT.

Medications for comorbid disorders: no information

Inclusion criteria:

1) A diagnosis of ADHD based on the DISC‐P2 conducted by a clinical psychologist. The diagnosis had to be confirmed by a child psychiatrist based on a comprehensive clinical interview with the child, and parent and teacher reports. The children had to, on two different occasions, receive a mean teacher rating of at least 1.5 on the hyperactivity factor or the hyperactivity index of the Conners Teachers Rating Scale.

2) Children had to be medication free for at last 2 weeks before evaluation.

3) Normal IQ (i.e.,WISC‐R ≥ 85).

4) Living with at least one parent, and have telephone access.

5) Positive response to methylphenidate.

Exclusion criteria:

1) Children with diagnosable neurological disorders.

2) Psychosis.

3) Significant medical illness.

4) Current physical or sexual abuse.

5) Chronic tic disorder or Tourette´s disorder.

6) DSM‐III‐R based developmental reading or arithmetic disorder, defined as a standard score in reading or mathematics on the Kaufmann Test of Educational Achievement of 85 or less.

7) Children with a diagnosis of conduct disorder.

Interventions

Number of participants allocated per group:

34 children were randomised to methylphenidate (M), 34 to M+ MultiModal Psychosocial Treatment (MPT), and 35 to M+ Attention Control Treatment (ACT).

Number of patients lost to follow up per group:

22 children failed to complete the study, 10 from the M alone group, 6 from the combined M+MPT group, and 6 from the M+ ACT group.

Format and duration of the intervention:

Duration of the trial: 2 years.

M+MPT= Methylphenidate + Parent training/family therapy, academic organizational skills training, individualized academic assistance, academic remediation (when necessary), social skills training, and individual psychotherapy. All the treatment modules were fully manual‐based and the manual was developed before the start of the study. Each component was delivered once a week in the first year and once monthly during the second year.

M+MPT= Methylphenidate + attention control program (delivered once a week in the first year and once monthly during the second year.)

A 75% of attendance was required.

Content of the intervention:

The Multimodal Psychosocial Treatment (MPT) was manual‐based and integrated several treatment components. Children received individualized academic assistance, organizational skills training, individual psychotherapy, social skills training and, when necessary, reading remediation. Parents received parent management training and counselling. Daily report cards were completed by teachers and formed the basis for a home‐based reinforcement program for targeted school behaviour and academic performance.

The Attention Control Psychosocial Treatment consisted of components parallel to those in the MPT but excluded the therapeutic content.

Medication: The medical treatment consisted of a medical manual and efforts was made to give each child a maximal dose of methylphenidate. There was a five week open methylphenidate titration trial before randomisation. No between groups difference were found in the methylphenidate medication.

Outcomes

Parent rated:

Hyperkinesis Index from Conners Parent Rating Scale.

Home situations questionnaire (parents).

SSRS ‐ Social Skills Rating Scale(parents).

Teacher rated:

Hyperactivity and Conduct Problems Factors from the Conners Teacher Rating Scale.

School Situations Questionnaire (teachers).

Children rated:

SSRS ‐ Social Skills Rating Scale (children).

Clinician rated:

Child Psychiatrists completed a DSM‐III R checklist for ADHD, ODD, conduct disorder symptoms, and a C‐GAS.

Observations:

School Observations: The Classroom Observation Code.

CTRS Hyperkinesis Index(rated by observers).

IOWA CTRS(rated by observers).

Children were evaluated at baseline, 6, 12, 18, and 24 months after baseline.

School observation: Social Interaction Observation Code.

Notes

Authors conclusions: There is no support for adding ambitious long‐term psychosocial interventions to methylphendidate to improve ADHD and ODD symptoms.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Clarification has been requested from the one of the trial investigators and Hovard Abikoff informed us in an email on 28 January 2011 that they had used a block randomisation scheme with blocks of 4 children. The groups were balanced for age, sex, ODD and ethnicity.

Allocation concealment (selection bias)

Low risk

Clarification has been requested from the one of the trial investigators and Howard Abikoff informed in an email that they had used sealed envelops.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

No blinding.

Blinding of outcome assessment (detection bias)
All outcomes

High risk

There were blinding on at least one of this reviews primary outcomes, in the rest of the outcomes there were no blinding.

Incomplete outcome data (attrition bias)
All outcomes

High risk

22 out of 103 children failed to complete the study.

Selective reporting (reporting bias)

Unclear risk

No prior statement of assessment tools. Design article published at the same time as trial article.

Vested interest bias

High risk

The trial was based in two large medical centres and the centres have extensive previous experience with research focused on ADHD and behavioural treatment.

Other sources of bias?

Unclear risk

Dr. Klein is a member of a pharmaceutical board.

Antshel 2003

Methods

Randomised Clinical Trial

Participants

120 children from 8‐12 years with ADHD, Inattentive type (n = 59) or ADHD, Combined type (n = 61).

Sex: 90 boys, 30 girls.

Ethnicity: 112 children were Caucasian, 6 African American, 2 Asian American.

Participants were recruited from newspaper advertisement and from consecutive referrals to a university based behavioural paediatric clinic specialized in ADHD and related disorders.

Comorbidity: 53 children had comorbid ODD, 29 had mood disorders, 11 had anxiety disorders, and 5 tic disorders.

Al 120 participants were taking stimulant medication (n = 110) or selective Serotonin reuptake inhibitor medications.

Sample size calculation not reported.

Pre randomisation: 142

Post randomisation:120

No statistical significant between‐groups differences in age, sex, or classroom placement, duration and severity of ADHD symptoms, or comorbid conditions.

Setting:Out patient clinic, Kentucky, USA.

Co‐medications for comorbid‐disorders: SSRI balanced between groups.

Inclusion criteria:

1) A diagnosis ADHD based on DSM‐IV (DICA‐R‐P). Only the children which scored >1.0 SD above the mean on the CBCL Attention subscale were included.

Exclusion criteria:

1) Not having an ADHD diagnosis.

2) Ages 8‐12, children with significant cognitive delays (IQ < 70)

3) Children with English as a second language. (Information received in an email from Kevin Antshel, 16 December 2010).

Interventions

Format and duration of the intervention:

The treatment groups consisted of 8 weeks treatment and there were 90 minutes group sessions for the children during consecutive weeks. The parents met in 3 parent sessions.

Content of the interventions:

All sessions were conducted by the same two therapists, a male doctoral student i psychology and a female master´s student in social work. The treatment were videotaped to ensure treatment consistency. The therapist followed a treatment manual. The child groups consisted of different methods to promote generalization of social skills.There were 6 themes which consisted of: Cooperation with peers, learning how to take others perspective, problem solving, recognizing and controlling anger, assertiveness, conversations (giving and receiving complements). The parent sessions consisted of information about the themes and content in the Childrens group and discussion of how to assess and monitor homework completion.

Mean attendance at the 8 treatment session was 94% for the diagnostically homogeneous and 92% for the diagnostically heterogenous treatment groups.

The control group was a wait list group.

Medication: No statistically significant between groups differences on medication type and dosage.

Outcomes

Parent rated:

SSRS ‐ Social Skills Rating Scale. (38 items) Higher scores indicate more social skills competences. The scale has indexes which are used as outcomes in this study; cooperation, assertion, self‐control, empathy (child version only) and responsibility (parents version only). Both the child and parent version of the SSRS, social skill domain scores range from 0 (less skilled) to 20 (high level of skills).

Child rated:

The SSRS ‐ Social Skills Rating Scale (34 items).

The outcome assessment were 8 weeks after the pretest and follow up were 3 months after the posttest. There were 100% completion rate at all tree assessment intervals( pre‐, post‐treatment and follow‐up).

Notes

Authors conclusion: The results of this trial do not support the efficacy of social skills training for children with ADHD.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

They used a computer generated randomisation process. Information received from Kevin Antshel in an email 13 July 2011.

Allocation concealment (selection bias)

Low risk

Allocation was concealed. Information received from Kevin Antshel in an email 13 July 2011.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

No blinding

Blinding of outcome assessment (detection bias)
All outcomes

High risk

No blinded outcome assessors. High risk of bias.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

There is stated that there was 100% completion rate.

Selective reporting (reporting bias)

Low risk

All of interest reported.

Vested interest bias

Unclear risk

No funding source reported.

Other sources of bias?

Unclear risk

Referal of patients, selection of ADHD‐I effort due to low prevalence can skew the data.

Bloomquist 1991

Methods

Randomised Clinical Trial.

Participants

A multistage identification process based on cut of scores in the CBCL: Child Behaviour Checklist teacher/parent resulted in a group of 64 children who were assessed by the Diagnostic Interview for Children and Adolescents‐ DICA‐R. Finally 52 children with ADHD were randomised to either the multi component CBT condition, a teacher intervention, and a wait list control group.

Sex: 36 boys and 16 girls in the age 8‐9 years.

Ethnicity: 95% was Caucasian students.

Comorbidity: 18 (35%) had also ODD.

Sample size calculation not reported.

The groups were highly comparable on the descriptive and subjective identification measures; age, IQ, Academic achievement, hyperactivity and self‐control behaviour, externalising, internalising behaviour on baseline.

Setting: Three suburban elementary schools in the same school district.

Co‐medications for comorbid disorders: no information

Inclusion criteria:

1) T≥60 on the CBCL‐Teacher.

2) Signed consent form.

3) TT≥60 on the CBCL‐Parent.

4) An ADHD diagnosis on the basis of DIACA‐R.

Exclusion criteria:

1) Mental retardation.

2) Epilepsy.

3) Severe emotional disorder.

4) Pervasive development disorder.

Interventions

Format and duration of the intervention:

The intervention consisted of Multicomponent Cognitive‐Behavioral Therapy Intervention(MLB): The intervention included coordinated child, parent, and teacher training components. The child component consisted of two one hour group sessions each week over a 10 week period (20 sessions). The teacher component consisted of one 2 hour in service and six 45‐60 minutes consultation over a 10 week‐ period. The parent intervention component consisted of seven 90 minutes group sessions.

Teacher‐only Intervention: This component consisted as the same teacher component as above but without the child only and the parent component.

Waiting‐list control: No intervention.

Content of the intervention:

The intervention based on Braswell and Bloomquist(1991) and Bloomquist and Braswell´s cognitive‐behavioural therapy program for ADHD children. A variety of cognitive‐ behavioural techniques were utilized in the child component such as: didactic instructions, modelling, role‐play exercises and so on.The teacher intervention was focused on, for example, problem solving in the classroom and on reinforcing appropriate behaviour and consequating disruptive behaviour. The parent intervention targeted to teach the parents about ADHD, to establish a positive trusting atmosphere among the parents, and to teach them cognitive/behavioural principles identical to those adressed in the teacher training component.

The child group was led by school psychologist, the parents' groups by therapist and the teacher intervention by a consultant.

The child and teacher interventions had almost 100% attendance.

Outcomes

Observations:

Structured behavioural observations(blinded to treatment assignment)

Children rated:

Self‐Control Rating Scale (SCRS) (33 item questionnaire, 7 point scale. The higher the score, the more the child lacked self‐control).

Teacher rated:

Conners Teacher Rating Scale (CTRS) (39 items questionnaire, 4 point Likert scale: from not at all (0) to very much (3))

Teacher Report‐Walker‐McConnell Scale of Social Competance and School Adjustment (43 items)

There was a comprehensive treatment manual for the MLB and for the teacher only intervention.

Notes

Key conclusions of the study authors: No difference between groups.

Authors refer to another paper by Bloomquist 1991. We cannot find this paper. We do not know if it was ever published.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

No description of the randomisation method used.

Allocation concealment (selection bias)

Unclear risk

No description of the allocation method used.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

No blinding.

Blinding of outcome assessment (detection bias)
All outcomes

High risk

The observers were blinded to treatment assignment but the teachers were not. No blinding on primary outcomes.

Incomplete outcome data (attrition bias)
All outcomes

High risk

16 excluded data sets with much likelihood to bias results.

Selective reporting (reporting bias)

Low risk

All of interest reported

Vested interest bias

Unclear risk

No funding stated.

Other sources of bias?

Unclear risk

No test for compliance of the intervention groups.

Cohen 1981

Methods

Randomised Clinical Trial

Participants

24 children were randomised to four different groups. Six received cognitive behaviour modification, eight received methylphenidate only, six received both treatments, and four were untreated.

Sex: 21 boys and three girls.

Age: 5‐6 years.

Comorbidity: No information.

Co‐medications for comorbid‐disorders: no information

Inclusion criteria:

1)Scores ≥1,5 on Conners abbreviated Teacher Rating Scale(CTRS).

2) IQ≥80 on WPPSI.

3)No neurological damage or psychosis.

Ethnicity: Canadian.

No sample size calculation.

Interventions

Format and duration of the intervention:

Cognitive Behaviour Treatment: Individual training 1 hour twice weekly sessions for a total of 20 sessions (10 weeks).

Content of the intervention:

The aim of the treatment was to teach the children to slow down, developing better problem solving ability, and to evaluate his/hers own performance.

Medication: Drug dosage was individually titrated. Dosages ranged from 10 to 30 mg methylphenidate pr. day. No information about medication balance between groups.

Outcomes

Teacher rated:

Conners Behaviour Rating Scale(teacher version)

PMFFT/MFFT(measuring cognitive impulsivity)

Parents rated:

Conners Behaviour Rating Scale.

Observation:

Observations in classrooms.

Motor impulsivity.

What Happens Next and Preschool Interpersonal Problem Solving Test measured social problem‐solving skills.

Nowick‐ Strickland Scale(Locus of control).

Richman‐Graham(emotional and social adjustment).

Notes

Key conclusion of the study authors: No difference in treatment effect.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Unclear.

Allocation concealment (selection bias)

High risk

No description of the allocation concealment, but four patients were moved between groups.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

No blinding.

Blinding of outcome assessment (detection bias)
All outcomes

High risk

There were blinding on at least one of this reviews primary outcomes, in the rest of the outcomes there were no blinding.

Incomplete outcome data (attrition bias)
All outcomes

High risk

Many tables different from text. No explanation. Lack of teacher responses.

Selective reporting (reporting bias)

Low risk

All apparent assessments are made.

Vested interest bias

Low risk

Funding ok, no previous research on the topic.

Other sources of bias?

High risk

The selection procedure of patients not stated in article.

MTA 1999

Methods

Randomised Clinical Trial

Participants

576 children with ADHD (DSM‐IV) aged to 9.9 years were randomised to either 14 month of medical treatment, intensive behavioural treatment, the two combined and standard community care.

Setting: Six multi site outpatient clinics in USA.

Sex: 465 boys and 111 girls.

Ethnicity: 61% white, 20% African American, and 8% Hispanic.

Comorbidity: 33.5% anxiety disorder, 14.3% conduct disorder, 39.9% oppositional‐defiant disorder, 3.8 % affective disorder, 10.9% tic disorder, 2.2%, other (bulimia, enuresis).

Co‐medications for comorbid disorders: balanced between groups.

Inclusion criteria:

1) Boys and girls, aged 7.0 ‐ 9.9 years (1 st‐4th grades), residing with primary caretakers for at least 6 months, who meet dimensional criteria for hyperactivity on the basis of parent end teacher rating scales and full diagnostic criteria for ADHD, Combined type.

Exclusion criteria:

1) Currently in hospital (inability to obtain school assessments).

2) Currently in another treatment study (confounding of assessments and treatments).

3) Below 80 on WISC‐III Verbal IQ, Performance IQ, or Full Scale IQ scores and on Scales of Independent Behavior (insufficient ability to participate in psychosocial interventions).

4) Bipolar disorder, psychosis, pervasive developmental disorder, severe obsessive‐compulsive disorder (treatment may be incompatible with MTA treatments).

5) Chronic, serious tics or Tourette´s Disorder (possible contraindication for stimulant treatment).

6) Neuroleptic treatment in previous 6 months (may need resumption, which is incompatible with MTA treatments).

7) Major neurological or medical illness that would interfere with study participation or require medications incompatible with MTA medications (inability to participate in MTA treatment).

8) History of intolerance to MTA medications (dangerous if participants assigned to arm involving medications).

9) Suicidal of homicidal (needs more intensive treatment than MTA provides).

10) Ongoing or previously undisclosed child abuse (risk of removal from home precludes parent intervention and consistent parent data).

11) Missed more than 25% of school days in previous 2 months (interference with teacher assessments and school intervention).

12) Another child in household already participating in MTA (cross‐arm contamination if two children in same household randomised to different arms).

13)Same classroom as child already participating in MTA (cross‐arm contamination if two pupils in same classroom are randomised to different arms).

14) Parental stimulant/cocaine abuse in past 2 years (possible co‐opting of child´s medications).

15) Inability of parent to speak English (inability to participate in parent training).

16) No telephone (inability to participate in telephone calls with therapists).

Interventions

There were four treatment conditions; Medication Treatment Group, Psychosocial Treatment Group, Combined Treatment (M+PS), and Community Care Group.

Format and duration of the treatment:

Medication Treatment Group: 1 month of blind titration. Monthly visits after the titration period, doses adjusted as indicated by monthly monitors.

Behavioural Treatment Group: Intense, Multi‐Component, including 27 group & 8 individual sessions of parent training, 16‐20 sessions teacher consultations, 8 week full time Summer Treatment Program, and 12 week of half‐time classroom behavioural specialist. No medication.

Combined Treatment Group: Integration of all treatment components in Medication Treatment Group and Behavioral Treatment Group.

Community Care Group: Treatment of own choosing in the community. No treatment provided by MTA.

Content of the Treatment:

Medical Treatment Group:

1 month of blind titration with methylphenidate for best dose, if unsatisfactory, then open titration with d‐amphetamine, pemoline, imipramine, others. Supplementary general advice and selected readings without systematic behavioural intervention.

Behavioural Treatment Group: Consisted of three major components: parent training, a two part school intervention component, and a child treatment component anchored in an intensive summer treatment program.

Outcomes

Parent rated:

Homework Problems Checklist

Social Skills Rating System

DISC 3.0

Conners Rating Scale

Child Behavior Checklist

SNAP‐IV

DSM‐IV Conduct Disorder Checklist

Consumer Satisfaction

Teacher rated:

Social Skills Rating System

Conners Rating Scale

Child Behavior Checklist

SNAP‐IV

Child rated:

WIAT

Social Skills Rating System

DISC 3.0

Self Report of Antisocial Behaviour

Observator rated:

Classroom Observations

Notes

The authors states that medication and combined treatment do not differ on teacher and parent rated social skills.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Adequate method used.

Allocation concealment (selection bias)

Low risk

Adequate method used.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

No blinding.

Blinding of outcome assessment (detection bias)
All outcomes

High risk

Blinded and unblinded raters.

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Imputation method?

Selective reporting (reporting bias)

Unclear risk

Where is the consumer satisfaction and the CBCL data reported? Clarification has been requested from one of the trial investigators, but we had received no answer when this review was finished.

Vested interest bias

Low risk

Funding okay.

Other sources of bias?

Low risk

Low risk.

Pfiffner 1997

Methods

Design: Randomised Clinical Trial.

Participants

Participants were recruited from newspaper advertisement and from consecutive referrals to a university‐based behavioural paediatric clinic specialized in ADHD and related disorders.

Children 8‐10 years with an ADHD diagnosis made on the basis of DSM‐III‐R criteria.

Sex: 19 boys, 8 girls.

Ethnicity: Patients were Caucasian except from 1 boy, who was African American.

Socioeconomic status were from middle to upper middle class. Two children were from single‐parent families.

Comorbidity:

25 children met criteria for ADHD and 2 met criteria for UADD. 19 children met criteria for comorbid oppositional defiant disorder, 3 for conduct disorder, 4 for separation anxiety disorder, 5 for overanxious disorder, and 2 for dysthymic disorder.

Only 12 of the children (44%) were receiving stimulant medication.

Sample size calculation not reported.

Pre randomisation: 27.

Post randomisation: 18.

Setting: University based paediatric clinic, USA.

Co‐medications for comorbid disorders: no information

Inclusion criteria:

1) Diagnosis of ADHD (DSM‐III‐R), a mean score at or above 1,5 on at least one of the parent‐completed sub scales assessing ADHD. behaviour from the CLAM rating scale or the SNAP‐R, a T score of at least 60 on the Attention Problem subscale of the CBCL.

Exclusion criteria:

Not reported. We have attempted to get information about this from the study investigators but have not succeeded in this attempt.

Interventions

Three conditions: Social skills training for the children (SST), Social skills training for the children with parent mediated generalisation (SST‐PG) and a wait list control group.

Format and duration of the intervention:

The two treatment groups attended 8 group sessions. There were assessment at pre and post treatment and follow‐up 3‐4 months post treatment. Children in the treatment groups received 90 min group sessions during consecutive weeks.

Content of the intervention:

The same two therapists were teaching in all the children groups. Six themes/modules were covered during the 8 weeks. 1) good sportsmanship, 2) accepting consequences, 3) assertiveness, 4) ignoring provocations, 5) problem solving, 6) recognising and dealing with feelings. Children were assigned homework to practice at home. The children received points for following the rules of the groups, participate and attend the sessions.The points could be exchanged for child‐selected games and activities during the last 10 minute for each group.

In the SST‐PG parent were used as a primary vehicle to program generalisation of the social skills learned in the SST groups to home and school settings. The parents group were led by a licensed psychologist. The parents went through the same group themes or agendas as the children did. The parents met with their childrens teacher and gave the teacher a template for the scorecard, also called the daily report card.The teacher scored the child on a 4 point scale and parents rewarded the child when the child scored high on the scale. There were a protocol for both the SST and the SST‐PG intervention.

The intervention groups were led by psychologist.

Outcomes

Parent rated:

Social Skils Rating System (SSRS) The Social Skills scale consists of 30 items on a Likert scale (0‐3).

Social Skills Scale (UCI) 10 items (5 point scale: 1‐5) (parent).

Consumer Satisfaction Questionnaire (12 items, 7 point scale (scores above 4 reflecting satisfaction and scores below 4 reflecting dissatisfaction).

Teacher rated:

Social Skils Rating System (SSRS). The Social Skills scale consists of 30 items on a Likert scale (0‐3).

Interviewers:

Test of social skill knowledge (six questions each scored from 1‐15)(scored by blinded raters).

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

No information given in the article. Clarification requested from the trial investigators and they reported in an email 26 May 2011 that it is not possible to find this data now.

Allocation concealment (selection bias)

Unclear risk

No information given in the article. Clarification requested from the trial investigators and they reported in an email 26 May 2011 that it was not possible to find this data now.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

No blinding.

Blinding of outcome assessment (detection bias)
All outcomes

High risk

There was blinding on at least one of this study's primary outcomes; in the rest of the outcomes there was no blinding.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Imputation method used. F.u. scores for 3 participants replaced by m.

Selective reporting (reporting bias)

High risk

The author informed in an email that the CLAM and SNAP were used post treatment, but not reported in the article. It was not possible to get the data because they had been lost over time.

Vested interest bias

Low risk

Funding okay. No previous publication on the topic.

Other sources of bias?

Unclear risk

$12 (f.u.) paid to families. $10, $25 for teachers.

44% of the participant were medicated with stimulant medication, but the number of medicated children in the different groups is not stated.

Pfiffner 2007

Methods

Design: Randomised Clinical Trial.

Participants

There were 69 children in the age 7‐ 11 years randomised to Child Life and Attention Skills Program (CLAS) or a control group who did not receive the intervention.

Setting: Outpatient clinic.

Sex: 46 boys, 23 girls.

Ethnicity: White 51%, Asian 16%, Hispanic 10%, Afro American 6%, and mixed 17%.

There were not any significant difference between group in the form of child age, sex, race, symptoms of hyperactivity/impulsivity, comorbid oppositional defiant disorder, anxiety or depression, IQ or academic achievement.

Comorbidity: ODD (23%), depressive (1%), anxiety (12%)

Co‐medications for comorbid disorders: no information

Inclusion criteria:

1) DSM‐IV diagnosis of ADHD‐I.

2) IQ > 80 (based on Wechsler Abbreviated Scale of Intelligence).

3) Living with at least one parent for the past year.

4) Attending school full time.

5) The school consenting to participate in school‐based treatment.

Exclusion criteria:

1) Families expecting to change medication status for their child during the study.

2) Children with visual or hearing impairment.

3) Severe language delay.

4) Major neurological illness.

5) Psychosis, or pervasive development disorder.

6) A child being in the same classroom as another participant or having a sibling who was already enrolled.

In the intervention group 7 children were lost to follow‐up and in the control group 8 children were lost to follow‐up.

Interventions

The treatment included three components administrated concurrently over 12 weeks: teacher consultation, parent training, and child skills training.

Format and duration of the treatment:

Child skills training: 8 (cohort:1‐4) and 10 (cohort 5) 1 ½ hours a week groups with child skills training in the 12 week period.

Parent Training: 8 (cohort:1‐4) or 10 (cohort 5) 1½ hour group sessions and 4 to 5 family sessions (cohort 2‐5).

Teacher Consultations: 1/2 hour overview of behavioural interventions and classroom‐based accommodations for ADHD followed by 4‐5 1/2 hour meetings of teacher, child, and therapist over the 12 week period.

Content of the intervention:

Child Skills Training: The training were divided into modules focused on skills for independence and skills for social competance.There were both behavioural interventions (for example, a reward based contingency management program) and cognitive‐behavioural interventions (for example, problem‐solving, the use of cues/verbal mediation strategies to stay on task and focused).

Parent Training:The modules in the child group were reviewed each week and the parents were taught methods to promote end reinforce the childs use of skills at home. The parents were also taught methods to managing ADHD.

Teacher consultations: A school‐home daily report card was designed and used (Classroom Challenge‐CC). Also a special notebook was created for each child containing copies of CC.

All the interventions were manual‐based. There were made some changes to the manuals to refine the interventions based on feedback from clinicians, participants, teachers, and parents.

Attendance: Parents in all cohorts participated in more than 95% of the group meetings.

Outcomes

Parent rated:

Child Symptom Inventory (parents and teachers) corresponds to DSM‐IV inattention symptoms and are rated on a 4 point scale (0 = never to 3 = very often).

The SCT scale (parents and teachers) consists of 15 SCT items rated on a 4‐point scale (0 = never to 3 = very often).

SSRS ‐ Social Skills Rating Scale. 30 items rated on a 3 point scale (never, sometimes, very often).

Organisational Skills (parents: 58 items, 4 point scale, 1 = never to 4 = just about all time).

Clinical Global Impression ‐ Improvement.

Teacher rated:

Child Symptom Inventory (parents and teachers) corresponds to DSM‐IV inattention symptoms and are rated on a 4 point scale (0 = never to 3 = very often).

The SCT scale (parents and teachers) consists of 15 SCT items rated on a 4‐point scale (0 = never to 3 = very often).

SSRS ‐ Social Skills Rating Scale. 30 items rated on a 3 point scale (never, sometimes, very often).

Organisational Skills (teacher: 38 items, 4 point scale, 1 = never to 4 = just about all time).

Clinical Global Impression‐Improvement.

Children rated:

Test of Life Skill Knowledge

Consumer satisfaction:

Parents: 100% very satisfied

35% improved or much improved

90% useful or very useful

Teachers: 32 of 36 rated the programme as appropriate

73% rated improved attentional difficulties

Children: 32 of 36 liked the group.

83% found the programme helped at home.

78% found the programme helped in school.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Random table. Information received from Pfiffner in an email 25 May 2011.

Allocation concealment (selection bias)

Low risk

Sealed.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

No blinding.

Blinding of outcome assessment (detection bias)
All outcomes

High risk

No blinding.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Imputation method used.

Selective reporting (reporting bias)

Low risk

All apparent assessment are made.

Vested interest bias

High risk

Has done previous trials

Other sources of bias?

High risk

Changes in treatment protocol. Timing for follow up differ; same school year vs next school year (both approximately 3 months after treatment but summer break between). Families and teachers were paid for each of the post treatment and follow‐up assessment.

Tutty 2003

Methods

Design: Randomised Clinical Trial.

Participants

Children 5‐12 with an ADHD diagnosis made on the basis of DSM‐IV criteria.

Sex: 75 boys and 25 girls

Ethnicity: White (49% intervention group, 38% control group), Afro‐American (4% IG, 2% CG), Asian (5% IG, 1% CG), Hispanic 1% IG, 0% CG).

Sample size calculation not reported.

Setting:Outpatient clinic, Washington, USA

Pre randomisation: 100

Post randomisation: Blinded follow‐up measures were completed by 97% and 98% of parent or guardian participants at 3 and 6 months after enrolment, respectively. Follow‐up completion rates for teacher participants yielded 92% and 75% for 3 and 6 months after enrolment, respectively. Participants with missing data did not differ from participants with complete data sets across time or any clinical, functional, and demographic variables according to the authors of the study article. For the ADHD Rating Scale outcome 2 children where lost to follow up. For the Child Attention Profile outcome totally 24 children where lost to follow‐up (16 in the IG and 8 in the CG).

Co‐medications for comorbid disorders: it was allowed but not stated if it were balanced between groups.

Inclusion criteria:

Diagnosis of ADHD (DSM‐IV)

Exclusion criteria:

1) Conduct disorder

2) Oppositional defiant disorder

3) Tourette syndrome

4) Affective disorder

5) Active alcohol or other substance abuse during previously 90 days

6) Chronic mental ilness

7) Patients enrolled in BSS class at GHC in the past.

Baseline characteristics: Mean baseline parented attention‐deficit hyperactivity disorder symptom scores were more symptomatic for the IG than for the CG, as well as the use of parent discipline practice. These between groups differences were adjusted before follow‐up analysis.

Interventions

Two conditions: Behavioural and social skills class versus control group (waiting list). Both groups received psychostimulant treatment.

Format and duration of the intervention:

The BSS intervention consisted of 8 once a week, 50 minute group sessions. The children were divided into one of three child groups according to age; 5‐7, 8‐10 and 11‐12 years. There was a parent only group at the same time as the child only group.

Content of the intervention:

The BSS intervention was based on an existing ADHD program previously developed by the CADD clinical team. The intervention are designed to enhance the children's overall understanding of ADHD and how to cope and manage with many of the physical and psychosocial problems connected to this condition. Each BSS session was based on a structured session by session agenda. The intervention was delivered by master levels therapist with at least two years experience. The child and parents were divided into a child only and a parent only group.

There was no significant between‐groups difference in psychostimulant use found at 3 (49.01% vs 53,6%; X2= 0.196, P = 0.658) months and 6 months (52,94% vs 39.02% x2 = 1.768, P = 0.184) for both IG and CG participants.

Co‐medication: allowed, but not stated if equal in groups.

Outcomes

Outcome assessment were conducted at 3 and 6 months.

Clinican rated:

The ADHD Rating Scale (18 items, Likert scale) assessed by a blinded research assistant at baseline, 3 months and 6 months. Assessment by telephone interviews of parents.

The Child Attention Profile (12 items. Likert scale) assessed by a blinded research assistant at baseline, 3 months and 6 months. Assessment by telephone interviews of teachers.

Notes

There was a third outcome used in this study, but it is not relevant for this review, because it measured the parents' discipline practice.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

The study used coin toss method performed by the research assistant and this is an adequate method according to the Cochrane Handbook.

Allocation concealment (selection bias)

Unclear risk

Information on this is not reported. Clarification about method of allocation concealment has been requested form the trial investigators, but no information on this topic was available at the time the review was prepared.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

No blinding.

Blinding of outcome assessment (detection bias)
All outcomes

High risk

Outcome assessment by telephone interviews of parents and teacher performed by a blinded research assistant. The parents not blinded, and therefore not an adequate method.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

There were used an ITT method.

Selective reporting (reporting bias)

Low risk

All of interest reported.

Vested interest bias

Low risk

Funding okay, and no previous trials on the topic.

Other sources of bias?

Unclear risk

The co‐medication not specified.

van der Oord 2007

Methods

Design: Randomised Clinical Trial.

Participants

Children aged 8‐12 years with ADHD diagnosed according to DSM‐IV.

Ethnicity: 40 children(89%) children from Caucasian parents, 1 child(2%) was from Caribbean parents, and 4(9%) from mixed origin.

Comorbidity: ODD/CD 61,9% in one group and 41,7% in the other.

Sample size calculation not reported.

Setting: Five different outpatient clinics in Netherland.

Co‐medications for comorbid disorders: no information

Inclusion criteria:

1) ADHD diagnosis based on DSM‐IV established with the parent version of DISC‐IV.

2) Total IQ of 75 or above based on the short version of WISC‐R.

3) Parents must give informed consent for their child to participate in the trial.

Baseline characteristic: One‐way ANOVAs and Chi2 analyses showed not significant differences between the two conditions in terms of baseline demographic characteristics. Furthermore one‐way ANOVAs showed no significant group differences.

Exclusion criteria:

1) Inadequate mastering of the Dutch language by the child or both parents.

2) A history of methylphenidate use.

Of the 50 randomised children one declined the methylphenidate only group and two of the children in the methylphenidate plus BT discontinued the intervention. Furthermore, one child was lost to posttest and follow up in the methylphenidate only intervention, one was omitted from analysis in the combined intervention group.

Medication:There were used a four‐week, pseudo‐randomised, multiple‐blind placebo‐controlled, crossover medication design, as described in the MTA study. The treatment groups did not differ on dose of methylphenidate either at baseline or posttreatment.

Interventions

Format and duration of the intervention.

50 children were randomised to either methylphenidate (n = 23) or methylphenidate plus multimodal behaviour therapy (n = 27).

The multimodal treatment consisted of child cognitive‐behaviour therapy, parent behaviour therapy and teacher behavioural training. The child cognitive‐behaviour therapy consisted of 10 weekly, 75 minutes group sessions, provided by two therapists. The parent behaviour therapy onsite of 10 weekly sessions of 90 minutes group therapy, provided by two therapists.

Content of the intervention.

There were used a treatment program and there were manuals in all the groups. In the child group there were used cognitive‐ behaviour techniques and the program for this group was adapted from Kendall and Braswell. It consisted of problem solving techniques, relaxation techniques, contingency management techniques, role playing, and guided practice. The parent group was based on Barkley´s training's manual "Defiant children: A clinicians manual for parent training." Components included, for example, psychoeducation on ADHD, structuring the environments, practicing positive attending skills and contingency management skills. The teacher training was based on the teacher training manual by Pelham and consisted of a two hour workshop, which consisted of, for example, psycho‐education on ADHD, structuring the classroom environment, and a daily report card.

Mean treatment attendance in the combined condition was 88.6%.

To ensure treatment compliance all therapist completed a treatment integrity checklist.

Outcomes

Parent rated:

DBDRS consist of 42 items and contains four sub scales: Inattention (9 items), Hyperactivity/Impulsivity (9 items), ODD (8 items), and CD (16 items). Has a 4‐point Likert scale (0‐3). The Inattention and the Hyperactivity/Impulsitivity sub scale were combined into one ADHD score. Higher scores indicate more increased symptoms.

SSRS ‐ Social Skills Rating Scale. (The parent version consist of 38 items. Has a 3‐point Likert scale rating from 0‐2.)

Parenting Stress Index(PSI)

Teacher rated:

DBDRS consist of 42 items and contains four sub scales: Inattention(9 items), Hyperactivity/Impulsivity (9 items), ODD (8 items), and CD (16 items).Has a 4‐point Likert scale (0‐3). The Inattention and the Hyperactivity/Impulsitivity sub scale were combined into one ADHD score. Higher scores indicate more increased symptoms.

SSRS ‐ Social Skills Rating Scale. The teacher version consist of 30 items. Has a 3‐point Likert scale rating from 0‐2.

Child rated:

Self‐Perception Profile for Children (SPPC).

State Trait Anxiety Inventory for Children (STAIC).

Notes

Authors conclusion is that there are no additive effect of multi modal treatment compared to medical treatment alone.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Information on this is not reported. Clarification about method of allocation concealment has been requested form the trial investigators, but no information on this topic was available at the time the review was prepared.

Allocation concealment (selection bias)

Unclear risk

Information on this is not reported. Clarification about method of allocation concealment has been requested form the trial investigators, but no information on this topic was available at the time the review was prepared.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

No blinding.

Blinding of outcome assessment (detection bias)
All outcomes

High risk

No blinding.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

All the participants lost to follow up were stated and lost to follow up not believed to influence results.

Selective reporting (reporting bias)

Low risk

No.

Vested interest bias

Unclear risk

Funding not stated.

Other sources of bias?

Unclear risk

Co‐medication not specified.

Waxmonsky 2010

Methods

Design: Randomised Clinical Trial.

Participants

Children aged 6‐12 years with ADHD diagnosed according to DSM‐IV‐TR

Ethnicity: 80,4% white, 10.7% African American, and 8,9% mixed. 7 children (12.5%) discontinued the study, 5 in the IG and 2 in the CG.

Sample size calculation not reported.

Of the 56 children 48 were diagnosed with ADHD‐combined type, 7 were diagnosed with ADHD‐inattentive type, and 1 was diagnosed with ADHD‐hyperactive/impulsive type. 22 children met criteria for comorbid conduct disorder and 24 for oppositional defiant disorder, leaving only 10 children with non comorbid ADHD.

Setting: Outpatient (attending school), Buffalo, USA

Co‐medications for comorbid disorders: no information

Inclusion criteria: ADHD based on DSM‐IV

Exclusion criteria:

1) Current or past history of seizures (not including benign febrile seizures).

2) Other physical conditions that precluded administration of atomoxetine (for example, marked cardiac conduction delay).

3) Documented failed trial of atomoxetine, defined as 3 weeks or more on treatment with at least 0.8 mg/kg/d, or a documented inability to tolerate this dose.

4) Serious forms of psychopathology other than ADHD, such as autism, bi‐polar disorder, schizophrenia, or any other psychopathology requiring urgent treatment with psychotropic medication.

5) Any history of major depression requiring treatment, or any past history of self‐harm or serious suicidal ideation.

6) An intelligence quotient of less than 75 (based on Wechsler Intelligence Scale for Children, 3rd edition).

7) No evidence of ADHD‐related impairment at school.

Baseline characteristics: 56 children randomised. 45 boys and 11 girls.

Medication: All patients received psychostimulant medications. No significant between group differences in mean doses of atomoxetine.

Interventions

8 week intervention + Medication versus Medication alone.

Number of participants allocated per group:

27 (Med); 29 (Med + BT)

Number of patents lost to follow up per group:

2 (Med); 5 (BT + Med)

Format and duration of the intervention:

The 8 week intervention consisted of:

Parent group: 8 week group, 2 hours session;1 session/week.

Child group ‐ SST: 8 week. 2 hours session;1 session/week.

Teacher: Daily report card.

Content of the intervention:

Parent group: Based on the COPE program and consisted of social learning's principals targeting at the Childrens behaviour and lack of impulse control. Group leaders were advanced graduate students or doctoral level clinicians.

Child group: Social skills training program. Group leaders were graduate students in clinical psychology.

Treatment compliance:

The parent intervention was based on a manual (COPE). It is unclear whether the child group intervention also was based on a manual.

62% of the parents attended 8 sessions, 62% attended 6 or more sessions. The children's attendance in the SST group is not reported.

Outcomes

Parent rated:

DBD (45 items, Likert scale 0 (not very much) to 3 (very much)).

SSRS (Social Skills Rating Scale) (55 items on the parent version, rated from 0 (not at all) to 2 (very often)).

Treatment satisfaction (Likert scale from 1 (strongly disagree) to 7 (strongly agree)).

Teacher rated:

DBD (45 items, Likert scale 0 (not very much) to 3 (very much)).

SSRS (Social Skills Rating Scale) (57 items on the teacher version, rated from 0 (not at all) to 2 (very often) and from 0(lowest 10%) to 5 (highest 10%).

APRS (Academic Performance Rating Scale) (19 items scale, 1‐5 Likert scale).

DRC (Daily Report Card).

Observations:

Observations of violence to classroom rules using Student Behaviour Teacher Response Observation Code.

Clinician ratings:

CGI(Clinical Global Impressions scale).

Classroom behaviour.

ADHD symptoms and functioning at home and at school.

Notes

Key conclusion of the author: Behavioural therapy improved ADHD symptoms at the home but not at school.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Clarification requested from the one of the trial investigators and Dan Wascbusch informed in an email 22 June 2011 that they had used a computer generated randomisation process

Allocation concealment (selection bias)

Low risk

Clarification requested from the one of the trial investigators and Dan Wascbusch informed in an email 22 June 2011 that the clinicians did not know the treatment assignment before it was assigned.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

No blinding.

Blinding of outcome assessment (detection bias)
All outcomes

High risk

No blinding.

Incomplete outcome data (attrition bias)
All outcomes

High risk

Clarification requested from the one of the trial investigators and Dan Wascbusch informed in an email that subjects were dropped if there was not sufficient information. Scores in indexes were computed if there were at least 50% of the items in the index answered and counted them missing if they were not. Dan Wascbusch also informed that they had essentially complete data pre‐treatment and nearly complete at post‐treatment. For teachers they had a lower response. They included whatever they had in the analyses and dropped subjects when there was not sufficient information, repeating this for each analysis.

Selective reporting (reporting bias)

Unclear risk

Protocol published in Clinicaltrials.gov after trial conduct. Publication and report in Clinicaltrials gov. is not consistent.

Vested interest bias

High risk

Fundings from and collaboration with Eli‐Lilly Company.

Other sources of bias?

Unclear risk

Co‐medication not specified.

Yuk‐chi 2005

Methods

Design: Randomised Clinical Trial

Participants

90 children with ADHD were randomised to psychosocial treatment plus methylphenidate versus methylphenidate treatment alone.

Children aged 7 ‐ 9.9 years.

Ethnicity: Chinese children.

Sample size calculation was made.

Sex: 77 boys, 9 girls.

Comorbidity: Anxiety 29%, Depression 6%, ODD 50%, Conduct Disorder 6%.

Setting: Community mental health center: Out patient clinic in Hong Kong

Socio demographic: No significant differences between the two treatment groups in demographic and social economic status, comorbid conditions, and additional intervention received in the first six months of the treatment.

Medication: All participants received methylphenidate treatment. No information about between group differences in the medical treatment.

Co‐medications for comorbid disorders: no information

Inclusion criteria:

1) ADHD‐Combined Type based on DSM‐IV criteria

2) Children in the age 7‐9.9 years.

3) Studying first to fourth grade.

4) Living with a parent, who is the major caretaker.

5) IQ>80.

6) No significant physical disability.

7) No stimulant medication (methylphenidate) use for more than 2 weeks previously.

8) Their parents willingness to accept stimulant medication and psychosocial intervention of this study.

9) The parents willingness to accept random allocation.

10) No parent suffering from intellectual impairment or current psychosis.

Interventions

There were three components in the psychosocial treatment; child training, cognitive‐ behavioural parent training, and school consultations.

Pre randomisation: 146

Post randomisation: 90

Form and duration of the treatment:

Child training: 24 weekly sessions. Each group session lasted for 1 hour and 30 minutes to 2 hours.

Cognitive‐Behavioral Parent Training: 18 weekly sessions in total. Each session lasted for 1 hour and 30 minutes to 2 hours.

School Consultations: There were two telephone consultations,

Content of the intervention:

The child training:The training provided a rich direct contingency management environment, in which the training of problem solving's skills and anger control management was provided. All sessions were videotaped to check treatment integrity. Themes were, for example, feelings, games, problem solving, stop & think, role play school and home.

Parent training: The child training and the parent training were developed to implement concommitantly.Themes in the group were for instance: know yourself, attention rules, stress management, child mood management, homework coaching.

School consultations: The therapist in the child groups talked to the teachers about implementations of classroom management strategies and review of the child's progress in school.

No protocol violations to both child and parent training treatment program were detected.

Outcomes

Parent rated:

SWAN rating scale, (30 items, 7 point scale, 1(slightly below average) to ‐3 (far above average).

Teacher rated:

SWAN rating scale.(30 items, 7 point scale, 1(slightly below average) to ‐3 (far above average).

Clinician rated:

MFFT(computer programme to measure impulsivity. Scores time taken to make the response, and total numbers of errors.)

Consumer satisfaction: At post treatment: 40% very useful, 60% useful.

Notes

Combined Medication + PST yielded benefits on primary ADHD symptoms and on conduct problems.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Table of random numbers, with block size of two.

Allocation concealment (selection bias)

Unclear risk

Unclear.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

No blinding.

Blinding of outcome assessment (detection bias)
All outcomes

High risk

No blinding on this reviews primary outcome.

Incomplete outcome data (attrition bias)
All outcomes

High risk

Type of imputation method used is unclear.

Selective reporting (reporting bias)

Low risk

Low risk.

Vested interest bias

Unclear risk

Yuk‐Chi So has done previous research on the topic.

Other sources of bias?

High risk

Have done previous research and no statement of funding.

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Abikoff 1985

Not a randomised clinical trial.

Carlson 2000

Not a randomised clinical trial.

Carlson 1992

Not a randomised clinical trial.

Chang 2004

Not a randomised clinical trial.

Corkum 2005

Only parent training programme.

Döpfner 2004

Intervention not eligible.

Ercan 2005

Not a randomised clinical trial.

Evans 2000

Not a randomised clinical trial.

Fabiano 2003

Not a randomised clinical trial.

Feinfield 2004

Not children with ADHD.

Fenstermacher 2006

Not a randomised clinical trial.

Frankel 1997

Not a randomised clinical trial.

Frölich 2002

Not a randomised clinical trial.

Gadow 1985

Article ‐ not a trial.

Gol 2005

Control group without ADHD.

Gonzalez 2002

Not social skills training.

Hinshaw 1984

Not a randomised clinical trial.

Hinshaw 2000

Not a suitable outcome.

Horn 1990

Not a control as specified in the review protocol.

Jensen 1999

A review.

Jensen 2001

Not adding relevant data to the review.

Klein 1997

Not social skills training.

Kolko 1990

Not all of the children was diagnosed with ADHD.

Kolko 1999

Not social skills training.

Langberg 2008

Not social skills training.

Langberg 2010

Not a suitable outcome for this review.

Lösel 2006

Participants under five years of age.

Miranda 2002

Intervention for the teachers, not a clinical ADHD diagnosis.

Miranda 2006a

Not a randomised clinical trial.

Miranda 2006b

Review.

Molina 2008

The control group is not suitable.

MTA 2009

Not adding necessary data to the review.

Pelham 1980

Not a randomised clinical trial.

Pelham 1993

Not a randomised clinical trial.

Pelham 2000

No relevant data for the review.

Pelham 2005

Not a randomised clinical trial.

Rosén 1984

Not social skills training.

Waxmonsky 2008

Not a randomised clinical trial.

Webster‐Stratton 2001

Participants under five years of age.

Webster‐Stratton 2004

Participants under five years of age.

Williams 1993

Not a randomised clinical trial.

Wolraich 1978

Not social skills training.

Characteristics of ongoing studies [ordered by study ID]

Safren 2011

Trial name or title

Compensatory executive functioning skills training for adolescents with ADHD.

Methods

Randomised efficacy study, single blind crossover assignment.

Participants

Adolescents from 14 to 18 years diagnosed with ADHD. Both genders.

Interventions

Twelve weekly treatment sessions either immediately upon enrolling in the study or after a four month‐waiting period. Cognitive behavioural therapy versus wait list control. This study, adapted from a similar research study for adults with ADHD, will examine whether cognitive behavioural therapy (CBT) plus medication is more effective at treating ADHD than medication therapy alone in adolescents with ADHD.

Outcomes

Primary outcome measures: Changes in ADHD symptoms, measured before randomisation, and at 4 months and 8 months follow up. Secondary outcomes measures: Changes in secondary symptoms af ADHD (for example, mood).

Starting date

October 2009. Estimated study completion date: May 2012.

Contact information

Principal Investigators: Steven A. Safren, Ph.D., Massachusetts General Hospital. Susan E. Sprich, Ph.D., Massachusetts General Hospital.

Notes

Clincaltrials.gov Identifier: NCT0109252

Storebø 2011

Trial name or title

Randomised social‐skills training and parental training plus standard treatment versus standard treatment of children with attention deficit hyperactivity disorder ‐ The SOSTRA trial.

Methods

The design is randomised two‐armed, parallel group, assessor‐blinded trial.

Participants

Children aged 8‐12 years with a diagnosis of ADHD are randomised to social‐skills training and parental training plus standard treatment versus standard treatment alone. A sample size calculation estimated that at least 52 children must be included to show a 4‐point difference in the primary outcome on the Conners 3rd Edition subscale for 'hyperactivity‐impulsivity' between the intervention group and the control group.

Interventions

Social skills training will consist of 8 weeks of group treatment with weekly sessions of one and a half hours and includes role play, exercises and games as well as home work which will include the parents. At the same time the parents are participating in parental training groups, that will focus on supporting the children's social training. Both the children and the parental groups are lead by two group therapists. The intervention will be additional to the received standard treatment.

The standard treatment consists of medical treatment, briefing, consulting and supporting conversations with a focus on securing compliance to the treatments and on aiding children and their families with the difficulties arising with the children's illness. Furthermore the parents participate in parental groups three times during the 8 weeks in which the experiment takes place. This group lasts 2 hours and is managed by two nurses who are attached to the ADHD‐ treatment group.

Outcomes

The outcomes will be assessed 3 and 6 months after randomisation. The primary outcome measure is ADHD symptoms. The secondary outcome is social skills. Tertiary outcomes include the relationship between social skills and symptoms of ADHD, the ability to form attachment, and parents' ADHD symptoms

Starting date

August 2009. Finished August 2011.

Contact information

Contact: Ole J. Storebø, psychol., MS [email protected]

Contact: Jesper Pedersen, MD, Phd. [email protected]

Notes

Clincal Trials.gov Identifier:NCT00937469

Data and analyses

Open in table viewer
Comparison 1. Social skills (SSRS)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Primary analysis: Social skills competences Show forest plot

7

Std. Mean Difference (IV, Random, 95% CI)

Subtotals only

Analysis 1.1

Comparison 1 Social skills (SSRS), Outcome 1 Primary analysis: Social skills competences.

Comparison 1 Social skills (SSRS), Outcome 1 Primary analysis: Social skills competences.

1.1 Primary analysis: Teacher‐rated social skills competences at end of treatment ‐ all eligible trials

5

392

Std. Mean Difference (IV, Random, 95% CI)

0.16 [‐0.04, 0.36]

1.2 Sensitivity analysis:Teacher‐rated social skills competences ‐ excluding the trial with longest intervention duration (also largest trial)

4

185

Std. Mean Difference (IV, Random, 95% CI)

0.19 [‐0.10, 0.48]

1.3 Teacher‐rated social skills competences ‐ longest follow‐up

1

18

Std. Mean Difference (IV, Random, 95% CI)

0.06 [‐0.86, 0.98]

1.4 Secondary analysis: Parent‐rated social skills competences at end of treatment ‐ all eligible trials

7

628

Std. Mean Difference (IV, Random, 95% CI)

0.22 [0.04, 0.40]

1.5 Secondary analysis: Participant‐rated social skills competences at end of treatment ‐ all eligible trials

2

188

Std. Mean Difference (IV, Random, 95% CI)

0.21 [‐0.09, 0.51]

2 Teacher‐rated social skills (Mean Difference) Show forest plot

4

185

Mean Difference (IV, Random, 95% CI)

1.81 [‐1.02, 4.64]

Analysis 1.2

Comparison 1 Social skills (SSRS), Outcome 2 Teacher‐rated social skills (Mean Difference).

Comparison 1 Social skills (SSRS), Outcome 2 Teacher‐rated social skills (Mean Difference).

3 Parent‐rated social skills competences (Mean Difference) Show forest plot

5

313

Mean Difference (IV, Random, 95% CI)

2.82 [‐0.92, 6.56]

Analysis 1.3

Comparison 1 Social skills (SSRS), Outcome 3 Parent‐rated social skills competences (Mean Difference).

Comparison 1 Social skills (SSRS), Outcome 3 Parent‐rated social skills competences (Mean Difference).

4 Walker‐McConnel Social skills Show forest plot

1

46

Mean Difference (IV, Fixed, 95% CI)

1.06 [‐0.47, 2.59]

Analysis 1.4

Comparison 1 Social skills (SSRS), Outcome 4 Walker‐McConnel Social skills.

Comparison 1 Social skills (SSRS), Outcome 4 Walker‐McConnel Social skills.

5 Social skills scale (UCI) parent‐rated Show forest plot

1

18

Mean Difference (IV, Fixed, 95% CI)

9.70 [6.07, 13.33]

Analysis 1.5

Comparison 1 Social skills (SSRS), Outcome 5 Social skills scale (UCI) parent‐rated.

Comparison 1 Social skills (SSRS), Outcome 5 Social skills scale (UCI) parent‐rated.

6 Child social skills knowledge scale Show forest plot

1

18

Mean Difference (IV, Fixed, 95% CI)

4.20 [1.99, 6.41]

Analysis 1.6

Comparison 1 Social skills (SSRS), Outcome 6 Child social skills knowledge scale.

Comparison 1 Social skills (SSRS), Outcome 6 Child social skills knowledge scale.

7 Social interaction observation ‐ negative behaviour Show forest plot

1

68

Mean Difference (IV, Fixed, 95% CI)

0.20 [‐0.11, 0.51]

Analysis 1.7

Comparison 1 Social skills (SSRS), Outcome 7 Social interaction observation ‐ negative behaviour.

Comparison 1 Social skills (SSRS), Outcome 7 Social interaction observation ‐ negative behaviour.

Open in table viewer
Comparison 2. General behaviour

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Primary analysis: Teacher‐rated general behaviour Show forest plot

3

Std. Mean Difference (IV, Fixed, 95% CI)

Subtotals only

Analysis 2.1

Comparison 2 General behaviour, Outcome 1 Primary analysis: Teacher‐rated general behaviour.

Comparison 2 General behaviour, Outcome 1 Primary analysis: Teacher‐rated general behaviour.

1.1 Primary analysis: Teacher‐rated general behaviour at end of treatment ‐ all eligible trials

3

358

Std. Mean Difference (IV, Fixed, 95% CI)

0.00 [‐0.21, 0.21]

1.2 Sensitivity analysis: Teacher‐rated general behaviour excluding the trial with longest intervention duration

2

290

Std. Mean Difference (IV, Fixed, 95% CI)

‐0.04 [‐0.27, 0.19]

1.3 Sensitivity analysis: Teacher‐rated general behaviour excluding the largest trial

2

104

Std. Mean Difference (IV, Fixed, 95% CI)

0.15 [‐0.24, 0.53]

1.4 Teacher‐rated general behaviour ‐ longest follow‐up

2

256

Std. Mean Difference (IV, Fixed, 95% CI)

‐0.23 [‐0.48, 0.01]

1.5 Secondary analysis: Parent‐rated general behaviour at end of treatment

1

254

Std. Mean Difference (IV, Fixed, 95% CI)

‐0.26 [‐0.51, ‐0.01]

Open in table viewer
Comparison 3. ADHD symptoms

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Teacher‐rated ADHD symptoms Show forest plot

8

Std. Mean Difference (IV, Random, 95% CI)

Subtotals only

Analysis 3.1

Comparison 3 ADHD symptoms, Outcome 1 Teacher‐rated ADHD symptoms.

Comparison 3 ADHD symptoms, Outcome 1 Teacher‐rated ADHD symptoms.

1.1 Primary analysis: Teacher‐rated ADHD symptoms at end of treatment ‐all eligible trials

6

515

Std. Mean Difference (IV, Random, 95% CI)

‐0.02 [‐0.19, 0.16]

1.2 Sensitivity analysis:Teacher‐rated ADHD symptoms excluding the trial with the longest treatment intervention

5

447

Std. Mean Difference (IV, Random, 95% CI)

‐0.06 [‐0.25, 0.12]

1.3 Sensitivity analysis: Teacher‐rated ADHD symptoms at end of treatment excluding the largest trial

5

261

Std. Mean Difference (IV, Random, 95% CI)

0.07 [‐0.18, 0.31]

1.4 Teacher‐rated ADHD symptoms ‐ longest follow‐up

2

79

Std. Mean Difference (IV, Random, 95% CI)

‐0.24 [‐0.90, 0.41]

1.5 Teacher‐rated ADHD symptoms ‐ MTA inattention outcome

1

254

Std. Mean Difference (IV, Random, 95% CI)

0.01 [‐0.23, 0.26]

1.6 Teacher‐rated Sluggish cognitive tempo end of treatment

1

66

Std. Mean Difference (IV, Random, 95% CI)

‐0.29 [‐0.78, 0.20]

1.7 Secondary analysis: Parent‐rated ADHD symptoms at end of treatment ‐ all eligible trials

7

654

Std. Mean Difference (IV, Random, 95% CI)

‐0.49 [‐0.79, ‐0.19]

Open in table viewer
Comparison 4. Subgroup analysis 1: trials with social skills training without parental training compared to social skills training combined with parental training

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Teacher‐rated Show forest plot

1

36

Mean Difference (IV, Fixed, 95% CI)

7.42 [‐1.42, 16.25]

Analysis 4.1

Comparison 4 Subgroup analysis 1: trials with social skills training without parental training compared to social skills training combined with parental training, Outcome 1 Teacher‐rated.

Comparison 4 Subgroup analysis 1: trials with social skills training without parental training compared to social skills training combined with parental training, Outcome 1 Teacher‐rated.

1.1 Teacher‐rated social skills training with parent training

1

18

Mean Difference (IV, Fixed, 95% CI)

5.60 [‐6.78, 17.98]

1.2 Teacher‐rated social skills training without parent training

1

18

Mean Difference (IV, Fixed, 95% CI)

9.30 [‐3.31, 21.91]

Open in table viewer
Comparison 5. Subgroup analysis 2: trials with ADHD including comorbidity compared to trials with ADHD and no comorbidity

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Parent‐rated ADHD symptoms at end of treatment Show forest plot

7

Std. Mean Difference (IV, Random, 95% CI)

Subtotals only

Analysis 5.1

Comparison 5 Subgroup analysis 2: trials with ADHD including comorbidity compared to trials with ADHD and no comorbidity, Outcome 1 Parent‐rated ADHD symptoms at end of treatment.

Comparison 5 Subgroup analysis 2: trials with ADHD including comorbidity compared to trials with ADHD and no comorbidity, Outcome 1 Parent‐rated ADHD symptoms at end of treatment.

1.1 Parent‐rated ADHD symptoms at end of treatment without comorbidity

1

97

Std. Mean Difference (IV, Random, 95% CI)

‐0.78 [‐1.19, ‐0.36]

1.2 Parent‐rated ADHD symptoms at end of treatment ‐ with comorbidity

6

557

Std. Mean Difference (IV, Random, 95% CI)

‐0.44 [‐0.76, ‐0.11]

Open in table viewer
Comparison 6. Subgroup analysis 3: trials with social skills training, parental training and medication compared to trials with social skills training and parental training without medication

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Social skills training, parent training, teacher consultations with and without medication Show forest plot

5

331

Std. Mean Difference (IV, Random, 95% CI)

0.26 [‐0.04, 0.56]

Analysis 6.1

Comparison 6 Subgroup analysis 3: trials with social skills training, parental training and medication compared to trials with social skills training and parental training without medication, Outcome 1 Social skills training, parent training, teacher consultations with and without medication.

Comparison 6 Subgroup analysis 3: trials with social skills training, parental training and medication compared to trials with social skills training and parental training without medication, Outcome 1 Social skills training, parent training, teacher consultations with and without medication.

1.1 Social skills training and parent training with medication

3

244

Std. Mean Difference (IV, Random, 95% CI)

0.19 [‐0.10, 0.48]

1.2 Social skills training, parent training without medication

2

87

Std. Mean Difference (IV, Random, 95% CI)

0.64 [‐0.48, 1.76]

original image
Figuras y tablas -
Figure 1

Risk of bias summary: review authors' judgements about each risk of bias item for each included study
Figuras y tablas -
Figure 2

Risk of bias summary: review authors' judgements about each risk of bias item for each included study

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies
Figuras y tablas -
Figure 3

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies

TSA 1
Figuras y tablas -
Figure 4

TSA 1

TSA 2
Figuras y tablas -
Figure 5

TSA 2

TSA 2
Figuras y tablas -
Figure 6

TSA 2

Comparison 1 Social skills (SSRS), Outcome 1 Primary analysis: Social skills competences.
Figuras y tablas -
Analysis 1.1

Comparison 1 Social skills (SSRS), Outcome 1 Primary analysis: Social skills competences.

Comparison 1 Social skills (SSRS), Outcome 2 Teacher‐rated social skills (Mean Difference).
Figuras y tablas -
Analysis 1.2

Comparison 1 Social skills (SSRS), Outcome 2 Teacher‐rated social skills (Mean Difference).

Comparison 1 Social skills (SSRS), Outcome 3 Parent‐rated social skills competences (Mean Difference).
Figuras y tablas -
Analysis 1.3

Comparison 1 Social skills (SSRS), Outcome 3 Parent‐rated social skills competences (Mean Difference).

Comparison 1 Social skills (SSRS), Outcome 4 Walker‐McConnel Social skills.
Figuras y tablas -
Analysis 1.4

Comparison 1 Social skills (SSRS), Outcome 4 Walker‐McConnel Social skills.

Comparison 1 Social skills (SSRS), Outcome 5 Social skills scale (UCI) parent‐rated.
Figuras y tablas -
Analysis 1.5

Comparison 1 Social skills (SSRS), Outcome 5 Social skills scale (UCI) parent‐rated.

Comparison 1 Social skills (SSRS), Outcome 6 Child social skills knowledge scale.
Figuras y tablas -
Analysis 1.6

Comparison 1 Social skills (SSRS), Outcome 6 Child social skills knowledge scale.

Comparison 1 Social skills (SSRS), Outcome 7 Social interaction observation ‐ negative behaviour.
Figuras y tablas -
Analysis 1.7

Comparison 1 Social skills (SSRS), Outcome 7 Social interaction observation ‐ negative behaviour.

Comparison 2 General behaviour, Outcome 1 Primary analysis: Teacher‐rated general behaviour.
Figuras y tablas -
Analysis 2.1

Comparison 2 General behaviour, Outcome 1 Primary analysis: Teacher‐rated general behaviour.

Comparison 3 ADHD symptoms, Outcome 1 Teacher‐rated ADHD symptoms.
Figuras y tablas -
Analysis 3.1

Comparison 3 ADHD symptoms, Outcome 1 Teacher‐rated ADHD symptoms.

Comparison 4 Subgroup analysis 1: trials with social skills training without parental training compared to social skills training combined with parental training, Outcome 1 Teacher‐rated.
Figuras y tablas -
Analysis 4.1

Comparison 4 Subgroup analysis 1: trials with social skills training without parental training compared to social skills training combined with parental training, Outcome 1 Teacher‐rated.

Comparison 5 Subgroup analysis 2: trials with ADHD including comorbidity compared to trials with ADHD and no comorbidity, Outcome 1 Parent‐rated ADHD symptoms at end of treatment.
Figuras y tablas -
Analysis 5.1

Comparison 5 Subgroup analysis 2: trials with ADHD including comorbidity compared to trials with ADHD and no comorbidity, Outcome 1 Parent‐rated ADHD symptoms at end of treatment.

Comparison 6 Subgroup analysis 3: trials with social skills training, parental training and medication compared to trials with social skills training and parental training without medication, Outcome 1 Social skills training, parent training, teacher consultations with and without medication.
Figuras y tablas -
Analysis 6.1

Comparison 6 Subgroup analysis 3: trials with social skills training, parental training and medication compared to trials with social skills training and parental training without medication, Outcome 1 Social skills training, parent training, teacher consultations with and without medication.

Summary of findings for the main comparison. Social skills training compared to no intervention

Social skills training compared to no intervention

Patient or population: Children aged 5 to 18 years with ADHD
Settings: All
Intervention: Social skills training
Comparison: No intervention

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Social skills training

Teacher‐rated social skills competences at end of treatment ‐ all eligible trials
(SSRS)

The mean score for teacher‐rated social skills competences at end of treatment in the intervention groups was
0.16 standard deviations higher
(0.04 lower to 0.36 higher)

392
(5 studies)

⊕⊕⊝⊝
low

Teacher‐rated general behaviour at end of treatment ‐ all eligible trials

The difference in mean scores for teacher‐rated general behaviour at end of treatment between the intervention and control groups was
0.00 standard deviations
(‐0.21 lower to 0.21 higher)

358
(3 studies)

⊕⊕⊝⊝
low

Teacher‐rated ADHD symptoms ‐ all eligible trials

The mean score for teacher‐rated ADHD symptoms at end of treatment in the intervention groups was

0.02 standard deviations lower
(0.19 lower to 0.16 higher)

515
(6 studies)

⊕⊕⊝⊝
low

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% confidence interval).

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

Figuras y tablas -
Summary of findings for the main comparison. Social skills training compared to no intervention
Table 1. Differences between protocol and review

Protocol

Review

Outcomes: In the protocol we stated that we would measure the two primary and the first two of secondary outcomes at short term (up to six months), medium term (six to 12 months), and long term (more than 12 months).

In the protocol we did not prespecify the most important comparisons for the 'Summary of findings' table.

In the review this has been changed to at the end of treatment and at the longest follow‐up. We have added definition of adverse outcomes according to the International Committee of Harmonization guidelines (ICH 1996).

In the review we used our two primary outcomes (teacher‐rated social‐skills and general behaviour) and the first secondary outcome (ADHD symptoms) in the 'Summary of findings' table.

Subgroup analysis: In the protocol we planned to perform subgroup analysis according to the following categories:
1. Children aged five to 11 years compared to children aged
12 to 18 years.
2. Social skills training in a group setting compared to
individual social skills training.
3. Trials with social skills training only compared to trials with
social skills training supported by parental training or supporting
efforts focused on parents/teachers.
4. Children with ADHD compared to children with ADHD
and comorbid behavioural disorders (conduct disorder,
oppositional disorder).
5. Children with ADHD plus depression, attachment
disorder, or anxiety disorders compared to children with ADHD
without these comorbidities.
6. Trials with low risk of bias compared to trials with high risk

In the review it was not possible to perform subgroup analysis 1, 2, 5, and 6 due to lack of sufficient data in the included trials.

Risk of bias: In the protocol we had not planned to evaluate blinding of participants and personnel.

In the protocol we stated that we would only use trials with low risk (or lower risk) of bias in the meta‐analysis.

In the review we also assessed the blinding of participants and personnel.

In the review we changed this decision to restrict meta‐analysis to trials with comparable risk of bias (for example, all low risk, all unclear, or all the trials are at high risk of bias), and perform sensitivity analyses accordingly.

Sensitivity analysis: In the protocol we stated that we would repeat the analysis taking different methods used to handle the missing data into consideration.

In the review we did not perform this due to lack of necessary data. We have analysed the data 'as reported'.

Figuras y tablas -
Table 1. Differences between protocol and review
Comparison 1. Social skills (SSRS)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Primary analysis: Social skills competences Show forest plot

7

Std. Mean Difference (IV, Random, 95% CI)

Subtotals only

1.1 Primary analysis: Teacher‐rated social skills competences at end of treatment ‐ all eligible trials

5

392

Std. Mean Difference (IV, Random, 95% CI)

0.16 [‐0.04, 0.36]

1.2 Sensitivity analysis:Teacher‐rated social skills competences ‐ excluding the trial with longest intervention duration (also largest trial)

4

185

Std. Mean Difference (IV, Random, 95% CI)

0.19 [‐0.10, 0.48]

1.3 Teacher‐rated social skills competences ‐ longest follow‐up

1

18

Std. Mean Difference (IV, Random, 95% CI)

0.06 [‐0.86, 0.98]

1.4 Secondary analysis: Parent‐rated social skills competences at end of treatment ‐ all eligible trials

7

628

Std. Mean Difference (IV, Random, 95% CI)

0.22 [0.04, 0.40]

1.5 Secondary analysis: Participant‐rated social skills competences at end of treatment ‐ all eligible trials

2

188

Std. Mean Difference (IV, Random, 95% CI)

0.21 [‐0.09, 0.51]

2 Teacher‐rated social skills (Mean Difference) Show forest plot

4

185

Mean Difference (IV, Random, 95% CI)

1.81 [‐1.02, 4.64]

3 Parent‐rated social skills competences (Mean Difference) Show forest plot

5

313

Mean Difference (IV, Random, 95% CI)

2.82 [‐0.92, 6.56]

4 Walker‐McConnel Social skills Show forest plot

1

46

Mean Difference (IV, Fixed, 95% CI)

1.06 [‐0.47, 2.59]

5 Social skills scale (UCI) parent‐rated Show forest plot

1

18

Mean Difference (IV, Fixed, 95% CI)

9.70 [6.07, 13.33]

6 Child social skills knowledge scale Show forest plot

1

18

Mean Difference (IV, Fixed, 95% CI)

4.20 [1.99, 6.41]

7 Social interaction observation ‐ negative behaviour Show forest plot

1

68

Mean Difference (IV, Fixed, 95% CI)

0.20 [‐0.11, 0.51]

Figuras y tablas -
Comparison 1. Social skills (SSRS)
Comparison 2. General behaviour

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Primary analysis: Teacher‐rated general behaviour Show forest plot

3

Std. Mean Difference (IV, Fixed, 95% CI)

Subtotals only

1.1 Primary analysis: Teacher‐rated general behaviour at end of treatment ‐ all eligible trials

3

358

Std. Mean Difference (IV, Fixed, 95% CI)

0.00 [‐0.21, 0.21]

1.2 Sensitivity analysis: Teacher‐rated general behaviour excluding the trial with longest intervention duration

2

290

Std. Mean Difference (IV, Fixed, 95% CI)

‐0.04 [‐0.27, 0.19]

1.3 Sensitivity analysis: Teacher‐rated general behaviour excluding the largest trial

2

104

Std. Mean Difference (IV, Fixed, 95% CI)

0.15 [‐0.24, 0.53]

1.4 Teacher‐rated general behaviour ‐ longest follow‐up

2

256

Std. Mean Difference (IV, Fixed, 95% CI)

‐0.23 [‐0.48, 0.01]

1.5 Secondary analysis: Parent‐rated general behaviour at end of treatment

1

254

Std. Mean Difference (IV, Fixed, 95% CI)

‐0.26 [‐0.51, ‐0.01]

Figuras y tablas -
Comparison 2. General behaviour
Comparison 3. ADHD symptoms

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Teacher‐rated ADHD symptoms Show forest plot

8

Std. Mean Difference (IV, Random, 95% CI)

Subtotals only

1.1 Primary analysis: Teacher‐rated ADHD symptoms at end of treatment ‐all eligible trials

6

515

Std. Mean Difference (IV, Random, 95% CI)

‐0.02 [‐0.19, 0.16]

1.2 Sensitivity analysis:Teacher‐rated ADHD symptoms excluding the trial with the longest treatment intervention

5

447

Std. Mean Difference (IV, Random, 95% CI)

‐0.06 [‐0.25, 0.12]

1.3 Sensitivity analysis: Teacher‐rated ADHD symptoms at end of treatment excluding the largest trial

5

261

Std. Mean Difference (IV, Random, 95% CI)

0.07 [‐0.18, 0.31]

1.4 Teacher‐rated ADHD symptoms ‐ longest follow‐up

2

79

Std. Mean Difference (IV, Random, 95% CI)

‐0.24 [‐0.90, 0.41]

1.5 Teacher‐rated ADHD symptoms ‐ MTA inattention outcome

1

254

Std. Mean Difference (IV, Random, 95% CI)

0.01 [‐0.23, 0.26]

1.6 Teacher‐rated Sluggish cognitive tempo end of treatment

1

66

Std. Mean Difference (IV, Random, 95% CI)

‐0.29 [‐0.78, 0.20]

1.7 Secondary analysis: Parent‐rated ADHD symptoms at end of treatment ‐ all eligible trials

7

654

Std. Mean Difference (IV, Random, 95% CI)

‐0.49 [‐0.79, ‐0.19]

Figuras y tablas -
Comparison 3. ADHD symptoms
Comparison 4. Subgroup analysis 1: trials with social skills training without parental training compared to social skills training combined with parental training

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Teacher‐rated Show forest plot

1

36

Mean Difference (IV, Fixed, 95% CI)

7.42 [‐1.42, 16.25]

1.1 Teacher‐rated social skills training with parent training

1

18

Mean Difference (IV, Fixed, 95% CI)

5.60 [‐6.78, 17.98]

1.2 Teacher‐rated social skills training without parent training

1

18

Mean Difference (IV, Fixed, 95% CI)

9.30 [‐3.31, 21.91]

Figuras y tablas -
Comparison 4. Subgroup analysis 1: trials with social skills training without parental training compared to social skills training combined with parental training
Comparison 5. Subgroup analysis 2: trials with ADHD including comorbidity compared to trials with ADHD and no comorbidity

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Parent‐rated ADHD symptoms at end of treatment Show forest plot

7

Std. Mean Difference (IV, Random, 95% CI)

Subtotals only

1.1 Parent‐rated ADHD symptoms at end of treatment without comorbidity

1

97

Std. Mean Difference (IV, Random, 95% CI)

‐0.78 [‐1.19, ‐0.36]

1.2 Parent‐rated ADHD symptoms at end of treatment ‐ with comorbidity

6

557

Std. Mean Difference (IV, Random, 95% CI)

‐0.44 [‐0.76, ‐0.11]

Figuras y tablas -
Comparison 5. Subgroup analysis 2: trials with ADHD including comorbidity compared to trials with ADHD and no comorbidity
Comparison 6. Subgroup analysis 3: trials with social skills training, parental training and medication compared to trials with social skills training and parental training without medication

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Social skills training, parent training, teacher consultations with and without medication Show forest plot

5

331

Std. Mean Difference (IV, Random, 95% CI)

0.26 [‐0.04, 0.56]

1.1 Social skills training and parent training with medication

3

244

Std. Mean Difference (IV, Random, 95% CI)

0.19 [‐0.10, 0.48]

1.2 Social skills training, parent training without medication

2

87

Std. Mean Difference (IV, Random, 95% CI)

0.64 [‐0.48, 1.76]

Figuras y tablas -
Comparison 6. Subgroup analysis 3: trials with social skills training, parental training and medication compared to trials with social skills training and parental training without medication